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CHAPTER I 
INTRODUCTION 
A. Classes of Proteases 
The field of proteases covers enzymes that are 
capable of cleaving proteins and peptides. Within this 
class there are sufficiently significant differences between 
groups of enzymes to allow for their further classification. 
This classification has recently been reviewed by McDonald 
(1985), and is briefly summarized below. 
Broadly speaking, proteases as a term, is reserved 
for a more general use to ref er to both endopeptidases 
(proteinases) and exopeptidases (peptidases). The former 
comprise that class of proteases that have been shown to 
cleave an internal bond in a polypeptide chain away from its 
terminal end. Exopeptidases on the other hand, need to 
have a free charged group and can cleave at or near the N-
terminal or C-terminal end of a protein or peptide. This 
primary classification of proteases references their 
specificity. 
An additional specificity-based classification is 
also applied to exopeptidases. Thus aminopeptidases, 
dipeptidyl peptidases and tripeptidyl peptidases attack the 
N-terminal of the substrate and remove one or two or three 
amino acids at a time, respectively. 
1 
Similarly, one can 
2 
have carboxypeptidases and peptidyl dipeptidases which 
attack the c-terminal end and remove one amino acid at a 
time or two amino acids at a time, respectively. There are 
also dipeptidases that are restricted to cleaving 
unsubstituted dipeptides, and tripeptidases that can remove 
an amino acid from either end of an unsubstituted 
tripeptide. A new class called omega peptidases has also 
been defined (McDonald and Barret, 1985) and is made up of 
enzymes which are capable of removing N-terminal residues 
that lack a free alpha-amino group, or c-terminal residues 
that lack a free alpha-carboxyl group. This class also 
includes exopeptidases that hydrolyze isopeptide bonds and 
other peptide bonds that do not link alpha-amino and alpha-
carboxyl groups. 
Within each of these two broad classes, 
endopeptidases and exopeptidases, further subdivisions have 
been attempted that are based on the realization that all 
proteases utilize one of four catalytic mechanisms (Hartley, 
1960) . Amendments to this original scheme have been 
proposed for naming and classifying endopeptidases 
(proteinases) (Barrett, 1980a). These define the following 
five classes: a) serine 
diisopropylphosphofluoridate 
proteinases 
(DFP)-sensitive, 
(EC 3.4.21; 
active at pH 
7-9), b) cysteine proteinases (EC 3.4.22; acetate-sensitive, 
active at pH 2-7), c) aspartic proteinases (EC 3.4.23; 
pepstatin-sensitive, active at pH 2-7), d) metallo 
3 
proteinases (EC 3.4.24; EDTA-sensitive active at pH 7-9), e) 
proteinases of unknown catalytic mechanism (EC 3.4.99). 
This catalytic classification is also applied to 
exopeptidases (peptidases), though to date no aspartic 
peptidase has been reported (McDonald, 1985). 
Endo- and exopeptidases that are classified as 
cysteine proteases include papain, bromelain, ficin and 
I ca theps in B. Pepsin and rennin belong to the aspartic 
proteases class, whereas collagenase, carboxypeptidase A, 
and angiotensin converting enzyme and the aminopeptidases 
are good examples of metallo proteases. 
The class that has perhaps been most widely studied 
and which probably constitutes the biggest group of known 
enzymes is the serine class. Within this class it is 
customary to refer to a few families of enzymes. One family 
is composed of trypsin-like enzymes which are distinguished 
by their preference for basic amino acid residues (discussed 
below) . Another family is made up of chymotrypsin-like 
enzymes which have a preference for hydrophobic amino acid 
residues and include chymase I, chymase II, and cathepsin G. 
Enzymes specific for praline comprise another family. The 
kallikrein family is a group of serine proteases that are 
involved in generating kinin activity, etc. These enzymes 
may not have evolved from each other, but may demonstrate 
common characteristics because they arose from a common 
progenitor gene (Woodbury and Neurath, 1980). 
4 
Some of the members of the trypsin-like family of 
proteases are the enzymes of the coagulation pathway (e.g. 
thrombin, factor Xa), the complement pathway (e.g. Cl 
esterase, factor D), the fibrinolytic pathway (e.g. 
plasmin, urokinase, tissue plasminogen activator), as well 
as tryptase (though only a recently identified enzyme) . 
Although enzymes within the trypsin-like family all have a 
primary'specificity for cleaving substrates on the carboxyl 
side of the amino acids arginine or lysine, they often 
exhibit very high substrate specificity. They may be able 
to hydrolyze only one bond in one protein of the coagulation 
cascade, for example. The specificity arises in part 
because of the requirement for a specific amino acid 
sequence on either side of the basic amino acid where 
cleavage occurs. This requirement is called secondary 
specificity. Frequently, a small synthetic substrate which 
has an amino acid sequence similar to that of the natural 
substrate in the region of the scissile bond can also be 
hydrolyzed. Related substrates with slightly altered 
sequence may not be cleaved. Thus, synthetic substrates can 
be used to define both the primary and secondary 
specificities of the protease and can be used to distinguish 
one protease from another even when their natural substrate 
is unknown. 
The present project will focus on a serine protease 
that is trypsin-like which has been isolated from the skin 
of rat. 
5 
A number of synthetic substrates will be used to 
gain a preliminary insight into the primary and secondary 
specificities of the enzyme. 
B. Physiological Functions of Proteases 
Proteolytic enzymes have been shown to play a role in 
some very important cellular and physiological processes. 
These include: chemotaxis, endocytosis, exocytosis, 
angiogenesis, tumorigenesis and fertilization (Woodbury & 
Neurath, 1980). They also play a role in inflammatory 
events such as blood clotting, clot lysis, degradation of 
cells and tissue matrix, cell transformation and chemotaxis 
of inflammatory cells (Barrett & McDonald, 1980) . They are 
also involved in intracellular protein and peptide 
degradation, and metabolism of hormones and neurotrans-
mitters (McDonald & Barrett, 1986). More recently these 
enzymes have also been implicated in prohormone processing 
(Schwartz, 1986). The study of proteases continues 
therefore to be an area of ceaseless and intense biochemical 
interest. 
C. Skin as a Source of Proteases 
Some of the specific features of the skin add further 
elements of significance to the study of these enzymes in 
this organ. 
The skin is the main organ that interfaces between an 
animal and its environment. This role requires among other 
things that replacement of cells in the skin take place much 
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more continuously than in other organs of the body. In fact 
the rate of cell division in the epidermis is much greater 
than in any internal organ (Spearman, 1973). Proteolytic 
enzymes have been implicated in cell proliferation 
(Schnebli, 1975; Fraki et al., 1983) and in regular cell 
turnover (Dean, 1980). One can therefore expect to find a 
range of proteases in the skin associated with its regular 
protein 'catabolism and its rapid proliferation. 
Another aspect of the skin that sets it apart from 
other organs is its size in terms of both area and weight. 
The skin is the largest organ of the body, comprising up to 
15-20 of the weight of the body in rats and humans 
(Harkness, 1971). This is an advantage as far as using it 
as a source for extracting proteases since much more tissue 
per animal is available and consequently more enzyme in some 
instances. 
A third feature of the skin that contributes to its 
uniqueness is its cellular composition. The skin is made up 
of at least seven different cell types that can trace their 
embryologic origins back to either the ectoderm, the neural 
crest, the mesoderm and even the bone marrow (Gilchrist, 
1984). Hence, there is a great liklihood that the proteases 
found in the skin may well be similar to proteases found in 
other organs of the body that derive from similar origins or 
share some of these cell types. Studies of the proteolytic 
enzymes of the skin can contribute to our understanding of 
this class of enzymes in several parts of the body. 
D. Significance of Studying Skin Proteases 
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The skin is most definitely a visual marker for aging 
and indeed has been accepted as a model for studying the 
aging process (Gilchrist, 1984). Its easy accessibility in 
live animals as well as some of its features discussed above 
are the strengths of this model. Since proteases are 
involved in cell turnover and proliferation, studies on the 
proteolytic activity of the skin may contribute to our 
understanding of the aging phenomenon. 
Epidermal serine proteases have been studied recently 
in patients with psoriasis (Dubertret et al., 1984), a skin 
disease that may affect up to 2% of a country's population 
(Mier & Cotton, 1976). The study suggests that these 
enzymes may be responsible for initiating the psoriatic 
lesion. 
In view of all of the special features of the skin 
described above, the investigation of proteases in the skin 
is of major significance. This study presents the isolation 
to homogeneity and characterization of a proteolytic enzyme 
from rat skin. The profile of its various characteristics 
suggests strongly that it is a hithertofore unknown trypsin-
like enzyme. In view of this "trypsin-like" nature of the 
enzyme and in order to facilitate discussion about this 
enzyme, we have decided to refer to it as "tryptidase". 
CHAPTER II 
LITERATURE SURVEY 
A. Proteolytic Enzymes in Skin 
Investigations into the proteolytic activity of the 
skin began with the identification of caseinolytic activity 
in saline extracts of animal and human skin (Sexsmith and 
Petersen, 1917). Since then an entire range of proteases 
have been partially purified and characterized from the skin 
of the human, rat, rabbit, toad, cat and guinea pig. 
1. Conditions for Extraction of Skin Proteases 
Jansen and Hopsu-Havu (1969) made a detailed study to 
determine the optimal conditions required to extract the 
caseinolytic activity of rat skin. Their findings are 
summarized by Hopsu-Havu et al. (1977), who have also 
reviewed extraction methods for other endopeptidases and 
exopeptidases from the skin. The main conclusion is that 
salt concentration in the extracting buffer plays an 
important role in extracting one or another kind of 
protease. 
2. Sources of Proteases in Skin 
Three classes of proteases have been identified by 
Mier & Cotton (1976) based on their cellular origin: one 
class is constitutive and free in the skin, the second class 
consists of enzymes that are of lysosomal origin; and the 
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third class comprises those that are induced under specific 
circumstances such as wounding and burning. 
3. Protease Inhibitors in Skin 
Inhibitors to a number of the proteases found in the 
skin have been identified and purified. These have been 
reviewed in relation to diseased states by Hopsu-Havu et al. 
(1981). The presence of these inhibitors in the skin is a 
further indication of the completeness and significance of 
the proteolytic enzyme system in the skin. 
4. Proteases Identified, Isolated and Characterized from 
Skin 
The chemical, physical, and catalytic properties of 
the known proteolytic enzymes of the skin have been reviewed 
in detail by Hopsu-Havu et al. ( 1977) and Fraki et al. 
( 19 8 3) . These proteases include representatives from the 
entire spectrum of classes and subclasses of proteolytic 
enzymes described by McDonald (1985). This extensive review 
data is not recapitulated here, but will be referred to as 
needed when "tryptidase" is compared with other enzymes in 
the Discussion. Instead the properties of skin proteases 
not covered in previous reviews are summarized briefly 
below. 
A neutral proteinase was purified and characterized 
from goat skin (Sivaparvathi et al., 1975). Based on amino 
acid analysis, its Mr was 40-45,000 (Sivaparvathi et 
al.,1980). A metalloproteinase that is active against the 
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elastase substrate succinyl-(Ala) 3-p-nitroanalide (SAPNA) 
but will not cleave insoluble elastin has been identified in 
human skin fibroblasts (Szendroi et al., 1984; Faller et 
al., 1985; Schwartz et al., 1986) and in blistering 
diseases (Oikarinen et al., 1986). A neutral cathepsin that 
may be different from a chymotrypsin-like cathepsin isolated 
from whole skin (Schecter et al., 1983) has also been . 
detected in human skin fibroblasts (Pall er et al., 1985; 
Schwartz et al., 1986). 
An aminoendopeptidase (Mr = 400, 000) has also been 
separated from cathepsins B, D, H, and L in newborn rat 
epidermis (Harvima et al., 1987) . While this study 
demonstrated the presence of cathepsin L in skin tissue for 
the first time, cathepsin H had been identified earlier as 
the BANA-hydrolase purified from rat skin by Jarvinen & 
Hopsu-Havu (1975) (Rinne et al., 1985). The purification 
and properties of aminoendopeptidase in rat epidermis were 
studied by Ito et al. (1984). 
Melanocytes isolated and grown from newborn human 
foreskin have been shown to have a 72,000 dalton plasminogen 
activator (PA) (Hashimoto et al., 1986). The PA activity in 
the culture medium was inhibited by anti-tissue PA IgG. 
Angiotensin converting enzyme was partially purified 
and characterized in mouse and human skin (Hara et al., 
1982) • The solubilized enzyme in both mouse and human 
tissue had a Mr of 430,000 in the presence of Triton x-100. 
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A soluble form of Mr = 330,000 was also found. 
Prolidase and prolinase were previously demonstrated 
in skin tissue. Another proline specific enzyme Proline 
iminopeptidase was also shown to be present in cultured skin 
fibroblasts in a single form (Butterworth and Priestman, 
1984a) . 
An interesting enzyme that has an o< -amidating 
activity dependent on copper and ascorbate was purified to 
homogeneity from Xenopus laevis skin (Mizuno et al., 1986). 
The enzyme was also partially purified from skin secretions 
of the organism (Mollay et al., 1986). 
5. Specific Proteases in Skin which Cleave the Trypsin 
Substrate, BAEE and the Chymotrypsin Substrate, ATEE 
In terms of the focus of the present project, our 
original interest was in those proteases that have trypsin-
like and/or chymotrypsin-like activities on the basis of 
cleavage of benzoyl-arginine ethyl ester (BAEE) and acetyl-
tyrosine ethyl ester (ATEE) , respectively. This interest 
derived from earlier studies on an enzyme from toad skin 
which has both activities. Therefore, trypsin-like and 
chymotrypsin-like enzymes will be discussed below in some 
detail. 
a. Carboxamidopeptidase (Cathepsin A) from Toad Skin 
An enzyme having both BAEE and ATEE activity has been 
purified to homogeneity from toad skin in our laboratory 
(Simmons & Walter, 1980). p-Aminobenzamidine-CH-Sepharose 
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(PAB) and concanavalin A-agarose (con A) specific affinity 
chromatography was used to purify the enzyme 3800-fold with 
a 22% recovery. The dual trypsin/chymotrypsin activities of 
the enzyme was seen with peptide substrates as well as with 
ester substrates. The enzyme hydrolyzes both of the 
neurohypophyseal hormones, oxytocin and vasopressin at the 
Leu8-Gly9-NH2 and Arg8-Gly9-NH2 bonds, respectively, thus 
suggesting the name carboxamidopeptidase. The pH optimum of 
the enzyme is 7.5. The enzyme is a serine protease and is 
significantly inhibited by the trypsin inhibitors p-
nitrophenol-p'-guanidinobenzoate (NPGB) 
methylumbelliferyl-p-guanidinobenzoate (MUGB) 
( 10 uM) , 4-
( 10 uM), basic 
pancreatic trypsin inhibitor (Trasylol) (0.1 mg/ml), tosyl 
lysine chloromethylketone (TLCK) (1.0 mM), leupeptin (44 
ug/ml), antipain (4.6 ug/ml) and by the chymotrypsin 
inhibitors, tosyl phenylalanine chloromethylketone (TPCK) 
(1.0 mM) benzyloxycarbonyl phenylalanine chloromethylketone 
(ZPCK) (0.2 mM) and chymostatin (65 ug/ml). A sulfydryl 
group is apparently near the active site since the enzyme is 
inhibited by p-chloromercuribenzoate (p-CMB) (0.05 mM). 
This effect is reversed by cysteine (Simmons & Walter, 
1980). The molecular weight of carboxamidopeptidase was 
estimated to be 100,000 by gel filtration in the presence of 
high salt. However SDS-polyacrylamide gel electrophoresis 
of the enzyme under reducing and non-reducing conditions 
indicated that the enzyme is composed of at least two 
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subunits (Mr = 48,000) each having a light and heavy chain 
each of molecular weights 19,000 and 28,000, respectively. 
The enzyme active site resides in the heavy chain. 
More detailed substrate specificity studies using 
vasopressin analogs indicated that the enzyme has a 
specificity for the penultimate amino acid which is broader 
than both trypsin and chymotrypsin (Simmons, 1981). Finally 
"carbo~amidopeptidase" was also shown to have 
carboxypeptidase-like activity on non-amidated peptide 
substrates, with a pH optimum of 5.5 (Simmons, 1981). Thus 
the enzyme can be classified as a serine carboxypeptidase 
with properties similar to those described for yeast 
carboxypeptidase Y (Hayashi, 1976) and mammalian cathepsin A 
(Logunov and Orekhovich, 1972). 
b. Rat Skin Carboxamidopeptidase? 
An enzyme that hydrolyzes the trypsin substrate BAEE 
and the chymotrypsin substrate ATEE, as well as other amino 
acid esters, was also purified 54-fold from rat skin (Seppa, 
1976). This enzyme is like the toad enzyme in that it has a 
molecular weight of 125,000 and is inhibited by 
diisopropylphosphofluoridate (DFP) ( O. 1 mM) and p-CMB ( o. 1 
mM) • However, TLCK, lima bean trypsin inhibitor (LBTI) , 
soybean trypsin inhibitor (SBTI), Trasylol and ovomucoid 
(OMTI) do not have any significant inhibitory effect on the 
enzyme. 
purify 
Arginine-Sepharose chromatography 
the enzyme. NaCl was required for 
was used to 
optimal BAEE 
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activity of the enzyme. The low purification factor 
indicates that the final preparation does not contain pure 
enzyme, possibly accounting for some of the differences from 
the toad enzyme. 
Based on the few similarities between the two 
enzymes, it was suggested that the rat skin enzyme, like the 
enzyme from toad skin, might turn out to be similar to . 
cathepsin A on further study (Simmons, 1979). 
In the rat, cathepsin A has been identified and 
characterized only in liver lysosomes (Taylor and Tappel, 
1973a; Taylor and Tappel, 1973b; Taylor and Tappel, 1974; 
Matsuda and Misaka, 1974; Matsuda and Misaka, 1975; Matsuda, 
1976), brain (Grynbaum and Marks, 1976; Marks et al., 1981). 
and muscle (Obled et al., 1980). To date, cathepsin A has 
not been described in rat skin. The only study which showed 
cathepsin A in mammalian skin is that of Volden et al. , 
(1976) which demonstrated CBZ-Glu-Tyr cleavage by guinea-pig 
epidermis. 
In order to broaden the study of enzymes having the 
dual BAEE and ATEE activities and to test the cathepsin-A 
hypothesis, we sought to purify this enzyme to homogeneity 
from rat skin using protocols developed in our laboratory 
for the toad enzyme. In attempting to do this, we isolated 
an enzyme that hydrolyzed BAEE but that had no activity 
against ATEE (Braganza & Simmons, 1986) and was not affected 
by inhibitors of chymotrypsin (Braganza & Simmons, 1987). 
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No such enzyme had been previously purified and 
characterized from rat skin. We therefore shifted our 
attention to the trypsin-like enzymes in the skin. 
6. Trypsin-Like Enzymes In The Skin 
A protease having "the pH activity curve of trypsin" 
was first identified in rat skin by Beloff & Peters (1945). 
The enzyme was shown to have optimum caseinolytic activity 
in the presence of 2. 5% KCl, while the use of 5% KCl 
resulted in greater efficiency of extraction of the 
proteinase activity. 
Histochemical studies were conducted on skin sections 
from rat, rabbit, guinea pig, mouse, dog and man. Trypsin-
like activity was detected only in the mast cells of dog and 
man (Glenner & Cohen, 1960). The observations were based on 
the hydrolysis of benzoyl-arginine B-napthylamide 
hydrochloride (BANA.HCl) and its inhibition by both DFP and 
benzoyl-arginine amide hydrochloride (BAA.HCl). 
Proteolytic activity of human skin slices was studied 
using the substrates BAEE, tosyl-arginine methyl ester 
(TAME), ATEE, and acetyl-tryptophan ethyl ester (ATrEE). 
Maximal BAEE activity was found in the epidermis, although 
considerable activity was also present in all skin layers 
(Yamura & Cormia, 1961). Extracts of the human skin slices 
also demonstrated high BAEE and TAME activity. 
a. Tryptase From Human Skin 
Fraki & Hopsu-Havu (1975) separated a BAEE 
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hydrolysing activity from an ATEE hydrolysing activity in 
human skin using Sephadex G-100 gel filtration and 
hydroxyapati te chromatography. The BAEE enzyme, which was 
partially purified 30-fold could split benzoyl-arginine p-
nitroanilide (BAPA) and histone proteins with an optimum pH 
of 7. 5-8. 2. While Trasylol (330 IU/ml) and TLCK (1. O mM) 
inhibited the enzyme, SBTI, LBTI and OMTI did not. 
significantly enough, no major effects of a serine protease 
inhibitor E-600 or of p-CMB were reported. The activity of 
the enzyme was considerably higher against TAME and acetyl-
glycyl-lysyl methyl ester (AGLME) than against BAEE. The 
molecular weight of the enzyme was 120, 000, al though in 
dilute buffer aggregates ranging from 340, ooo to 930, ooo 
were formed (Fraki & Hopsu-Havu, 1972a). 
This human skin enzyme has been ref erred to as 
tryptase and its subsite specificity has been studied 
(Tanaka et al., 1983) . The enzyme has an extended 
substrate-binding site with a high specificity for two basic 
residues. A role in the processing of prohormones and 
proproteins has been suggested for the enzyme. The enzyme 
was also found to be labile in the absence of salt in this 
study, although high salt concentrations had an inhibitory 
effect. 
A monoclonal anti-tryptase antibody raised against 
tryptase from human pulmonary mast cells binds to dermal 
mast cells and to washed dispersed keratinocytes (Schwartz 
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gt. al., 1985), thus indicating the cellular origin of the 
enzyme in the skin. Mastocytosis extracts of human skin 
have also been shown to contain markedly increased levels of 
tryptic proteinases suggesting a mast cell origin (Fraki et 
al., 1986) 
b. Characteristics of Tryptase from Other Human Tissue 
Sources 
. 
Tryptase has been identified as the predominant 
neutral protease of human mast cell secretory granules in 
studies conducted on dispersed pulmonary mast cells 
(Schwartz et al., 1981) . The enzyme has also been well 
purified from this source (Schwartz et al., 1981; Schwartz, 
1985) and based on SDS-polyacrylamide gel electrophoresis 
has been shown to have a tetrameric subunit structure 
composed of two subunits of molecular weights 37, 000 and 
35,000. Both units apparently contain active sites 
(Schwartz et al., 1981) and· are immunogenically related 
(Smith et al., 1984; Schwartz, 1985). Heparin, a component 
of rat and human mast cells has a stabilizing effect on the 
enzyme. The stabilization is through direct interaction 
with the enzyme rather than by an indirect ion-binding 
mechanism. In Tris-buffered saline in the absence of 
heparin an inactive 34,000 dalton form is detected (Schwartz 
and Bradford, 1986a) . 
The enzyme has the ability to rapidly inactivate 
human high molecular weight kininogen (HMWK) (Maier et al., 
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1983). Tryptase cleaves HMWK without generating any kinin 
contractile activity. on the other hand, no significant 
cleavage of low molecular weight kininogen (LMWK) or 
destruction of its reactivity with kallikrein was detected 
(Schwartz et al., 1984). Tryptase can also destroy 
fibrinogen in the presence and absence of heparin with 
minimum fibrinolytic activity. The enzyme does not 
hydrolyze plasminogen (Schwartz et al., 1985). Tryptase has 
no kallikrein or kininase activities and neither activates 
nor destroys prekallikrein (Schwartz et al., 1985) 
Immunocytochemical studies have further confirmed the 
localization of this enzyme to the mast cell of the lung 
(Smith et al., 1984). These authors have developed a 
procedure to isolate the enzyme from whole human lung after 
autopsy. The enzyme obtained by their procedure is similar 
to the pulmonary mast cell tryptase, except that it has a 
slightly lower molecular weight. The enzyme activity 
decreases with increasing NaCl concentration. Tryptase is 
apparently present in both the types of mast cells 
identified in human tissue (Irani et al., 1986). One type 
(TC) has both tryptase and chymotryptic activity and the 
other type (T type) has only tryptase activity. This is an 
interesting observation in light of earlier discoveries that 
there are two types of mast cells in the rat, type T and 
type AT, which contain the chymotrypsin-like enzymes RMCPI 
and RMCPII, respectively (Woodbury et al., 1981). 
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A tryptase that is immunologically identical to the 
one from human lung was identified in the mast cells of 
human pituitary connective tissue (Cromlish, et al., 1987). 
using Western blotting, at least five different size forms 
of the enzyme were shown to be present in human tissue. 
These authors also showed that the first four amino acids of 
the NH2-terminal sequence of the enzyme are homologous to 
that of'trypsin and other serine proteases. 
An enzyme partially purified from human uterine 
cervix (Ito et al., 1980) has been considered to be tryptase 
(Cromlish et al., 1987). The molecular weight of the enzyme 
and its inhibitor profile and proteinase activity compare 
favorably with the tryptases from other sources mentioned 
above. 
c. Tryptase from Rat Mast Cells 
A rat mast cell tryptase has also been isolated and 
characterized recently (Kido et al., 1985a). The enzyme is 
associated with an inhibitor (trypstatin) that affects its 
activity above pH 7.5. In the absence of the inhibitor, it 
is activated by 10 mM cac1 2 and is inhibited by the trypsin 
inhibitors BPTI, SBTI and o< 1 -anti trypsin. With trypstatin 
present, however, only o<.1-anti trypsin had an effect on the 
enzyme. The molecular weight of the enzyme-inhibitor 
complex was determined to be approximately 144, 000 by gel 
filtration, while that of trypstatin is about 7600. A 
factor Xa substrate, Boc-Ile-Glu-Gly-Arg-MCA was the most 
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rapidly cleaved of the substrates tried with the enzyme. 
However, TAME, an important tryptase substrate was not 
assayed. It has been suggested (Kido et al., 1985b) that 
the enzyme is activated together with · mast cell 
chymotrypsin-like proteases by IgE-receptor bridging, a 
process which plays a role in triggering the process of mast 
cell degranulation. 
d.' Other Trypsin-Like Enzymes In the Skin 
Hydrolysis of the trypsin-like substrate BAEE has 
been detected in guinea pig skin and the activity has been 
partially purified and characterized (Song et al., 1969). 
The enzyme is inhibited by SBTI ( 1. 67 X 10-5 M) , Trasylol 
(300 units) and TLCK (5.12 mM). Injection of the 
preparation intradermally resulted in an inflammatory 
reaction and prolonged increase in vascular permeability to 
plasma proteins. 
A permeability factor of Mr = 35, 000 with serine 
protease-like activity was also extracted from guinea pig 
skin. The activity was purified 292-fold using 
hydroxyapatite, diethylaminoethyl cellulose and Sephadex G-
75 column chromatography (Yamamoto and Kambara, 1978). 
Activation of the factor is adversely affected at high salt 
concentrations On Sephadex G-100. At high salt 
concentrations the Mr of the enzyme is approx. 80,000. It 
is activated by dialysis against a 67 mM phosphate buffer at 
pH 5.8-6.4 (Yamamoto et al., 1978). SBTI (0.5 mM) and DFP 
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(0.5 mM) inhibit the activity but EDTA (1 mM) and pepstatin 
( 1 mM) do not. It has a pI of 4. 5, and the evidence 
indicates that the factor can activate prekallikrein and may 
be similar to the plasma Hageman factor (Kozono et al., 
1980) . 
Soybean trypsin inhibitor affinity chromatography was 
used to purify (254-fold) a proteinase from human skin of 
Mr = 28', ooo (Hatcher et al., 1977). Complete inhibition of 
the enzyme occurs in the presence of o< 2-macroglobulin (1 
uM), ot 1-antitrypsin (13 uM), Cl inactivator (8 uM), DFP (5 
uM) , and SBTI ( 9 uM) . TLCK ( 5 uM) inhibits the enzyme 
significantly. No effect was seen of Trasylol ( 1000 KI 
units), Kunitz pancreatic trypsin inhibitor (KPTI) (30 uM), 
EDTA (2 mM), or TPCK (5 uM). Injection of the preparation 
into rabbit skin induced polymorphonuclear leukocyte 
infiltration into the cutis and edema (Levine et al., 1976). 
B. Goals and Objectives of this Project 
It is clear from the discussion above that there is 
trypsin-like activity in skin tissue arising from different 
enzymes. These have not been purified to homogeneity and 
characterized from rat skin tissue. Since our earlier 
studies indicated that we may have discovered a new trypsin-
like enzyme in rat skin, our goal has been to purify this 
enzyme to homogeneity and to characterize it chemically, 
physically, enzymatically and structurally. A purification 
scheme has been optimized to give maximum yield of the 
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enzyme in minimum time. In addition, the molecular weight, 
isoelectric point, N-terminal sequence, inhibitor profile, 
assay conditions, stability of the enzyme with respect to pH 
and temperature, the pH activity optimum and substrate 
specificity of the enzyme has been studied. These data will 
be used to substantiate our claims concerning the novelty of 
this enzyme. 
CHAPTER III 
MATERIALS AND METHODS 
A. Materials 
The sources of the animals, reagents and chemicals 
are listed below according to the experiment in which they 
. 
were used. Reagents and materials used in more than one 
experiment are listed only once. 
1. Purification Scheme 
Male rats (Sprague Dawley), 45-60 days old were from 
Holtzman, Madison, Wi. NaCl was obtained from Mallinckrodt, 
st. Louis, Mo. while NaHP04 and NaH2Po4 were from 
Mallinckrodt or Fisher Sci. Co., Pittsburg, Pa. 
Ethylenediaminetetraacetic acid (EDTA), agarose-glycyl-
glycyl-p-aminobenzamidine gel (A-Gly-Gly-PAB) (lot # 54F-
9580 & 84F-9610), benzamidine.HCl and NaN3 were bought from 
Sigma Chem. Co., St. Louis, Mo. Enzyme grade (NH4 ) 2so4 was 
obtained from Schwarz Mann Biotech. Div. of ICN Biomedicals, 
Inc. , Cambridge, Ma. Dialysis tubing was from Spectrum 
Medical Inds. , Inc. , Los Angeles, Ca. Concanavalin A-
agarose gel (lot # 10355) was obtained from Bethesda 
Research Laboratories, Gaithersburg, Md. The Centricon-3 O 
microconcentrator units were from Amicon Division, W. R. 
Grace & Co., Danvers, Ma. 
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2. substrates Used in standard Assays and Substrate 
Profile Studies 
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All amino acids are of the L-configuration unless 
otherwise indicated. BAEE, benzoyl-L-arginine (BA), ATEE, 
acetyl-L-tyrosine (AT), TAME, tosyl-L-arginine (TA), 
benzoyl-L-arginine methyl ester (BAME) , benzoyl-L-arginine 
p-nitroanilide (BAPNA), benzoyl-L-arginine B-napthylamide 
(BANA) were from Sigma Chemical Co. S-2484, S-2444, S-2266, 
S-2288, S-2251, S-2238 were from Kabi Vitrum, Stockholm, 
Sweden or Helena Laboratories, Beaumont, Tx. Spectrozyme 
Ca, Spectrozyme pKal and Spectrozyme PCa were from American 
Diagnostica Inc., Greenwich, Ct. Bz-Pro-Phe-Arg-p-
nitroanilide acetate, Spectrozyme PL, H-D-Val-Gly-Arg-p-
nitroanilide hydrochloride, Chromozym P were from Pentapharm 
Ltd. Substrate c1E-1 was from Immuno Diagnostics, Vienna, 
Austria. CBS 31.39 and CBS 34.47 were from Diagnostica 
Stage, Ansieres, France. Chromozym TH, Chromozym PL, and 
Chromozym U were from Boehringer Mannheim, Indianapolis, In. 
(The majority of the p-nitroanilide substrates was the kind 
gift of Dr. J. Fareed, Dept. of Pathology, Loyola Univ. of 
Chicago, Maywood, Il.) 
3. Protein Assays 
Bradford Reagent was the product of Bio Rad 
Laboratories, Richmond, Ca., and bovine serum albumin (BSA) 
was purchased from Sigma Chemical Co. 
4. Storage Experiments 
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Carbowax ( 2 o M) was a gift of Dr. Richard Schultz, 
Dept. of Biochemistry, Loyola Univ. of Chicago. Acetone was 
supplied by American Sci. Prods., McGaw Park, Il. 
5. pH Studies 
All anionic buffers were prepared from sodium salts. 
sodium borate, sodium citrate, sodium phosphate (mono and 
dibasic), succinic acid and sodium hydroxide were from 
Fisher 'sci. co. Sodium acetate was from J.T. Baker 
Chemical Co., Phillipsburg, NJ and Tris (base and HCl) was 
from Sigma Chemical Co. 
6. Inhibitors 
SBTI, LBTI, ovoinhibitor, OMTI, ~-1 antitrypsin, 
hirudin, concanavalin A, MUGB, TPCK, ZPCK, TLCK, p-CMB, 
Mncl 2 , antipain, leupeptin, chymostatin, 
pepstatin, bestatin, dithiothreitol 
elastatinal, 
(DTT) I 2-
mercaptoethanol, and E-amino caproic acid were all obtained 
from Sigma Chemical Co. NPGB was purchased from Nutritional 
Biochemical Corp. , Cleveland, O. DFP was obtained from 
Aldrich Chemical Co., Milwaukee, Wiand stored as a 240 mM 
solution in isopropanol at -20°. Trasylol was a product of 
Farbenfabriken Bayer AG. cacl 2 , CoC1 2 , and MgC1 2 were from 
Fisher Sci. Co. and Hgcl 2 was from J. T. Baker Chem. Co. 
7. Gel Filtration 
The molecular weight standards, rabbit muscle 
aldolase, ovalbumin, glutamate dehydrogenase and 
ribonuclease were obtained from Pharmacia Fine Chemicals. 
B-Amylase was from Sigma Chemical Co. 
a. SDS Gel Electrophoresis 
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Acrylamide and N,N'-methylene-bis-acrylamide (BIS) 
were purchased from Biorad Laboratories. Lauryl Sulfate, 
N,N,N' ,N'-tetramethylethylenediamine (TEMED), bromophenol 
blue, Dalton Mark VII-L (molecular weight standards 
mixture), and coomassie brilliant blue were the products of 
Sigma chemical Co. Acetic acid was from Mallinckrodt and 
methanol from American Sci.Prods. [3H]-DFP (3.9 Ci per 
mmol) was from New England Nuclear Co., Boston, Ma. 
Scintillation fluid, Ecoscint, was from National 
Diagnostics, Somerville, NJ. 
9. Isoelectric Focusing 
Precast Ampholine-containing polyacrylamide gels (pH 
3.5-9.5) (PAG-plates) were the product of LKB-produkter AB, 
Bromma, Sweden and the isoelectric focusing standard kit was 
from Pharmacia Fine Chemicals (pH 3.0-6.5 with colored dye 
marker) or from Sigma Chemical Co. (pH 3.0-9.5). 
10. Peptide and Protein Digestion 
Bradykinin, oxytocin and vasopressin were purchased 
from Ba chem Inc, Torrance, Ca. or Vega Biotechnologies, 
Tucson, AZ. Azocoll, casein, and haemoglobin were the 
products of Sigma Chemical Company. 
B. Methods 
1. Purification Scheme 
The following steps were used to purify the trypsin-
like enzyme from rat skin: 
a. Tissue Preparation 
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Male Sprague Dawley rats, 45-60 days old were 
sacrificed and their skins removed. Skins not immediately 
used for enzyme extraction were stored frozen at -20° and 
were thawed out overnight at 4° before use. The fur was 
then clipped away as close as possible to the epidermis 
using a'pair of Oster Professional Animal Grooming Clippers 
(Model A-5) with a No. 80, size 40 blade. Rats have a 
cutaneous muscle called the fil..!.. cutaneus trunci covering the 
lateral thoracic and abdominal wall from the shoulder to the 
base of the tail (Hebel and Stromberg, 1976). This 
extremely thin muscle sheet which is very closely appended 
to the dermis was first scraped off using sharp anatomical 
razors. 
The skins were next rinsed and washed in 0.65% saline 
and then minced in a Universal No. 3 meat grinder through 
two cycles. 
b. Extraction 
The minced skin was then homogenized in 0.025 M 
sodium phosphate containing 0.001 M EDTA and 0.5 M NaCl, pH 
7.0 (phos-EDTA-0.5 M NaCl-7.0) (1:9, w/v) in a Waring 
blender (Model PB-5) . Homogenization was carried out at 
high speed at 40 c for six, 20 sec intervals with 20 sec 
rest intervals in between. 
c. Ammonium Sulfate Precipitation 
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The fur and other tissue remnants were removed from 
the homogenate by filtration under vacuum, in a cold room, 
through a Buchner funnel lined with a nylon mesh. The 
filtrate was collected and brought to 25% (NH4 ) 2so4 by the 
addition of 138 g of the solid salt per liter of filtrate. 
The solution was then allowed to stand undisturbed for 
between 4-6 h. It was then centrifuged at 13,700 x g for 15 
min at 4° c. The sediment was discarded and the resulting 
supernatant was brought to 
rapid addition of 361.5 
80% (NH4 ) 2so4 saturation by the 
g per liter (of 25% saturated 
supernatant) (Taylor, 1953) . This solution was allowed to 
stand unstirred for 14 h and then centrifuged. The sediment 
was collected and resuspended in 100 ml o. 025 M sodium 
phosphate containing o. 001 M EDTA and o. 5 M NaCl, pH 6. o 
(phos-EDTA-0.5 M-NaCl-6.0), and then dialyzed against two 
changes of 6.5 1 each of the same buffer. I n s o 1 u b 1 e 
materials in the retentate were removed by centrifugation at 
23,700 x g for 15 min at 40. 
d. Agarose-Glycyl~Glycyl-p-Aminobenzamidine 
Chromatography 
The centrifuged retentate was then applied at room 
temperature to an agarose-glycyl-glycyl-p-aminobenzamidine 
affinity column (1. 5 x 20 cm) which had been equilibrated 
with phos-EDTA-0.5 M-NaCl-6.0. An LKB peristaltic pump was 
used to maintain a steady rate of 25 ml/h. The sample 
reservoir was maintained on ice during the procedure. When 
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the sample application was completed, the column was washed 
with one column volume (25 ml) of 0 .025 M sodium phosphate 
containing 0.02 % NaN3 and 0.5 M NaCl, pH 6.0 (phos-NaN3-o.5 
M NaCl-6.0). The column was then placed at 4° C for 1 hand 
then washed with one column volume of cold phos-NaN3-o.5 M 
NaCl-6.0. The enzyme was then eluted using phos-NaN3-o.5 M 
NaCl-6.0 containing 0.1 M benzamidine.HCl. 
e. Concanavalin A-Agarose Chromatography 
When one third of a column volume (approx. 10 ml) of 
the elution buffer had been passed through the A-Gly-Gly-PAB 
column, the eluent was directed into a concanavalin A-
agarose column (1 x 10 cm) equilibrated with phos-NaN3-o.5 M 
NaCl-6. O and the flow rate was immediately reduced to 10 
ml/h. The two affinity columns connected in series were 
further washed with 40 ml of the benzamidine-containing 
buffer. The first column was subsequently removed from the 
system and the concanavalin A-agarose column was then washed 
with one column volume (10 ml) of phos-NaN3-0.5 M-NaCl-6.0 
at a flow rate of 5 ml/h. One third column volume (3.5 ml) 
of a solution of 100 mg/ml of o<-methyl-D-mannoside in phos-
NaN3-o.5 M-NaCl-6.0 was passed through the column and the 
flow was stopped. 
from the column 
One hour later, the elution of the enzyme 
was continued using the same buffer. 
Fractions of 1 ml were collected in polystyrene tubes. 
Fractions containing BAEE activity were pooled and then 
concentrated to 25 ul in each unit, using four Centricon-30 
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microconcentrator units. The buffer of the sample was then 
changed to phos-EDTA-0.5 M-NaCl-6.0 by two dilution-
concentration cycles using 2 ml of this buffer for each 
dilution. Enzyme from all four microconcentrator units was 
pooled. Each unit was then washed three times with 200 ul 
of the buff er which was then added to the enzyme pool to 
give a final volume of 2.5 ml pure enzyme. The concentrated 
enzyme was stored at 40 in a polystyrene tube. 
f. Regeneration of Specific Affinity Columns 
At the end of each purification the A-Gly-Gly-PAB and 
the con-A column were regenerated for future use. The A-
Gly-Gly-PAB column was washed with two column volumes (50 
ml) of phos-EDTA-0.5 M-NaCl-6.0 containing 8 M urea, 
followed by 4 column volumes (100 ml) of the same buffer 
without urea. Both solutions were applied to the column 
under gravity at room temperature. 
The con-A column was regenerated using a modification 
of the method of Pitlick and Nemerson (1976). Two column 
volumes ( 2 O ml) of a buffer consisting of 100 mM sodium 
acetate, 0.5 M NaCl, 10 mM calcium chloride, 10 mM magnesium 
chloride, 0.02% NaN3 , pH 6.0 were pumped into the column at 
10 ml/h at 40. Both columns were then stored at 40 till 
further use. 
2. Enzyme Assays 
a. Esterase Activity 
Hydrolysis of BAEE was monitored spectrophotometri-
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cally (Schewert and Takenaka, 1955). A 1 ml assay volume 
was used consisting of o. 9 ml of enzyme ( 100-150 ng) in 
o.025 sodium phosphate, 1 mM EDTA, pH 7.5 (phos-EDTA-7.5) 
and 0.1 ml of 10 mM BAEE in distilled deionized H2o. The 
change of absorbance with time was recorded at 253 nm at 250 
in a Gilford Response spectrophotometer for intervals of 5 
or 15 mins. One unit of activity is defined as 1 umole of 
. 
substrate hydrolysed per minute and was calculated by the 
formula: 
unit activity = fl A253_;~m_i~n~~~~~~­l:J,. A253 for total cleavage 
X 1 umole BAEE 
1 
where A A253 for total cleavage is the difference in 
absorbance between lmM BA and lmM BAEE ( O. 9 5 Abs. uni ts) 
Specific activity is defined as the units of activity per mg 
of protein. The cuvettes were washed between assays with 
phos-EDTA-1 M-NaCl-7.0 buffer to ensure removal of any 
residual activity due to enzyme adsorbed to the surface of 
the cuvettes. 
b. Amidase Activity 
Hydrolysis of the amide substrates S-2288, S-2238, 
Spectrozyme PCa and Chromozym PL, was monitored 
spectrophotometrically in a manner similar to BAEE. The 
change in absorbance over time was monitored at 405 nm 
(Svendsen et al., 1972) at 250 in a Gilford Response 
spectrophotometer. The use of the Gilford Response 
spectrophotometer was convenient for these assays since it 
made comparisons with the BAEE assays described above easy. 
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However, its use was necessitated due to the fact that 
assays for the 23,700 x g step of the purification scheme 
had particulate matter in them and so could not be assayed 
on the Multistat rrrR centrifugal analyzer which was used to 
obtain a substrate profile for the amidase activity of the 
enzyme (see below). A unit of activity is defined 
identically as for the esterase activity, and is given by 
the formula: 
unit activity = 6 A405;min X 1 umole subst. b, A405 for total cleavage 1 
where A A405 for total cleavage is the difference in 
absorbance between 1 mM of p-nitroaniline (p-NA) and lmM of 
the pertinent amide substrate used. The specific activity 
is again defined as activity units per mg of protein. 
3. Protein Determination 
The Bradford protein micro assay was used in order to 
determine the protein concentration of the enzyme 
(Bradford, 1976). Bovine serum albumin was used as a 
standard. A595 was determined on a Gilford Response 
spectrophotometer. 
4. NaCl Concentration Dependence of Extraction of 
BAEE Activity 
Three rat skins were processed and minced as 
described above in the tissue preparation step of the enzyme 
purification scheme. The minced tissue was then divided 
into two equal halves by wet weight. The first half was 
homogenized in phos-EDTA-0.5 M-NaCl-7.0 and the second half 
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was homogenized in phos-EDTA-1 M-NaCl-7. O as described in 
step 1 b of the purification scheme above. An aliquot from 
each half was then centrifuged at 23,700 x g. The 
supernatant was assayed for BAEE activity using the standard 
assay described above. 
5. Time Course of Extraction of BAEE Activity 
The uncentrifuged O. 5 M NaCl extracts and the 1 M 
NaCl extract from the study above were allowed to stand at 
40 in a cold room. An aliquot was removed from each extract 
at intervals of 2 h and centrifuged at 23, 700 x g at 40. 
The amount of BAEE activity in each supernatant was then 
determined using the BAEE assay described above except that 
phos-EDTA-1 M-NaCl-7.0 was used as the assay buffer. 
Aliquots were removed at O h, 2 h, 4 h, 6 h, and 8 h 
respectively. 
6. Pilot Study for Ammonium Sulfate Precipitation 
A pilot study was conducted in order to determine the 
cutoff limits for the percent (NH4 ) 2so4 so that this 
purification step could be optimized (Clark & Switzer, 
1977). The uncentrifuged 1 M NaCl extract was used in this 
study. The extract was filtered under vacuum through cheese 
cloth in a Buchner funnel to remove tissue fragments and 
particulate matter. Aliquots (50 ml) of the filtrate were 
then each subjected to precipitation by the addition of 
(NH4 ) 2so4 to different percentages of saturation. The salt 
was mixed until it had dissolved completely and the mixtures 
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were allowed to sit undisturbed overnight at 40 c. The 
mixtures were then centrifuged at 13,800 x g at 40 c for 15 
min. After discarding the supernatant, the precipitate was 
resuspended in 10 ml of phos-EDTA-0.5 M-NaCl-6.0 and 
centrifuged at 23,500 x g at 40 c for 15 min. The 
supernatant was then assayed for protein and BAEE activity 
as described above. BAEE activity and protein concentration 
. 
expressed as a percent of the values for the untreated 
filtrate, were both plotted as functions of % (NH4) 2so4 
saturation on the same graph. The optimum cutoff points 
which give maximum activity recovery with minimum protein 
recovery were determined. The resuspended (NH4) 2so4 was not 
dialyzed and no attempt was made to compensate for possible 
(NH4 )2S04 inhibition at higher concentrations of the salt. 
7. Determination of Storage Conditions 
The ability of the enzyme to survive a range of 
storage conditions was determined. In all cases the 
activity of enzyme stored at 40 C in phos-EDTA-0.5 M-NaCl-
6.0 was used as a standard to compare residual activity. 
a. Storage at RT in Phos-EDTA-0.5 M-NaCl-6.0 
A sample of purified enzyme in phos-EDTA-0.5 M-Nacl-
6.0 was allowed to sit at room temperature. Aliquots of the 
enzyme were then removed to determine residual activity. 
Aliquots were removed initially every 2 h for up to 10 h and 
then once every 24 h for up to 8 days. The standard BAEE 
assay was used to determine activity. 
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b. Storage at -20Q in Phos-EDTA-0.5 M-NaCl-6.0 
Purified enzyme in phos-EDTA-0.5 M-NaCl-6.0 was 
stored in a -20° freezer. At intervals of 24 h for up to 8 
days the enzyme was removed from storage, allowed to thaw, 
and assayed for residual BAEE activity as described in 
section a above and then refrozen. 
c. Effect of Lyophilization 
An aliquot of enzyme was quickly frozen using a dry 
ice-acetone bath and then lypohilized in a Labconco Freeze 
Dryer. The lyophilized sample was stored at 4o for 8 days 
and then reconstituted in distilled deionized H2o and 
assayed for residual BAEE activity. A sample of enzyme 
frozen in the dry ice-acetone bath but not lyophilized was 
used as a control. 
d. Effect of Vacuum Drying in the Presence of 2% 
Carbowax 
Two aliquots of enzyme containing 2% 20 M Carbowax 
were dried under vacuum in a Savant Speedvac Concentrator 
model RT-100. One aliquot was then stored at room 
temperature and another at 40 C. After 8 days, both samples 
were reconstituted in distilled deionized H2o and assayed 
for residual BAEE activity as described above. 
8. Effect of pH 
Citrate (pH 2.5-4.0), acetate (pH 4.0-5.5), succinate 
(pH 5.0-6.0), phosphate (pH 6.0-8.0), Tris-HCl (pH 7.0-9.0), 
and borate (pH 8. 5-10. o) buffers were prepared at 250 C. 
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Each buffer was 0.1 M and no attempt was made to equalize 
ionic strengths. 
buffers. 
Sodium salts were used in all the anionic 
a. pH Stability 
A fixed aliquot of enzyme was brought to o .1 ml in 
each of the buffers described above and incubated for 2 h at 
25° c. Assay buffer (0.8 ml of 0.1 M phosphate, pH 7.5) was 
then added to each incubation mixture. Enzyme activity was 
then determined following the addition of O .1 ml of 10 mM 
BAEE. 
b. pH Optimum 
The buffers mentioned above were used in place of the 
standard buff er in the BAEE assay to determine the pH 
optimum of the enzyme. The reference cuvette contained BAEE 
in 0.1 M phosphate, 
hydrolysis of BAEE 
pH 7. 5, in each case. Non-enzymatic 
was determined for each buffer in the 
absence of enzyme and then subtracted from the activity 
observed with enzyme. The AA253 for total cleavage, used 
to calculate the activity uni ts, was determined in each 
buffer. Average rates were determined over a 15 min period. 
9. Temperature Studies at pH 7.5 
An aliquot of enzyme was brought to 0.1 ml in phos-
EDTA-7 .5 and then preincubated at various temperatures for 
3 o min. The enzyme mixture was then assayed for residual 
BAEE activity at 250 using the standard assay described 
above. 
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10. Effect of NaCl Concentration on BAEE Activity 
Phos-EDTA-7.5 and phos-EDTA-1 M-NaCl-7.5, were 
prepared as stock buffers. The stock buffers were then 
mixed in appropriate proportions to give buffers containing 
no NaCl, 0.2 M NaCl, 0.4 M NaCl, 0.6 M NaCl, 0.8 M NaCl, and 
1 M NaCl. The purified enzyme was then brought to 0.9 ml in 
each of these buffers and assayed for BAEE activity as 
described in the standard assay above. With the maximum 
activity recovered serving as a standard, the % activity was 
plotted as a function of NaCl concentration. 
11. Inhibition Profile Studies 
A set of chemical modification agents, protein 
protease inhibitors, microbial protease inhibitors, and 
metal ions were tested for their effect on the enzyme. In 
each case the standard BAEE assay was used to determine the 
effect of the inhibitor on the enzyme. 
a. Chemical Modification Agents 
The effect of chemical modification agents on the 
enzyme was studied by preincubating enzyme and inhibitor in 
phos-EDTA-7.5 in a total volume of 0.04 ml at 250 C for 10 
min in the assay cuvette. The entire mixture was then 
assayed for residual activity by adding assay buffer and 
BAEE to the cuvette. Enzyme incubated similarly but without 
inhibitor, was used as a control. In cases where an organic 
sol vent was needed to prepare a solution of an inhibitor, 
the pertinent solvent was included in the control incubation 
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mixture. 
b. Protein Protease Inhibitors 
All protein protease inhibitors used were water 
soluble. Enzyme and inhibitor were preincubated in phos-
EDTA-7. 5 in a total volume of 0.1 ml at 250 for 5 min. The 
entire mixture was then used as above to determine activity. 
An incubation mixture without inhibitor served as a control. 
c. Microbial Protease Inhibitors 
A reaction mixture of inhibitor and enzyme was 
prepared in a total volume of 0.9 ml and immediately assayed 
for activity. A reaction mixture without enzyme was used as 
a control. When an inhibitor required an organic solvent to 
dissolve it, a corresponding amount of solvent was usually 
included in the control. 
d. Effect of Metal Ions 
The following chloride salts were used to study the 
effect of a series of heavy metal ions on the purified 
enzyme: MgC1 2 , MnC1 2 , CoC1 2 , Cacl 2 , and HgC1 2 . Stock 
solutions (200 mM) of each of these salts were prepared in 
distilled deionized H2o. An aliquot of each stock solution, 
sufficient to give a concentration of 10 mM (2 mM for HgCl2) 
in a final assay volume of 1 ml, was brought, together with 
enzyme, to 0.9 ml in phos-EDTA pH 7.5 and assayed for BAEE 
activity as described in the standard assay above. Blanks 
contained the corresponding amount of metal ion concentra-
tion in each case (except for the HgCl2 assay). 
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12. Time Course of Inactivation by DFP 
The enzyme was preincubated with 0.1 M DFP in phos-
EDTA-0. 5 M..:.NaCl-6. O in a total volume of O. 04 ml for time 
periods ranging from O to 30 min. At each time point, the 
entire preincubation mixture was assayed for residual BAEE 
activity using the standard assay described above. Enzyme 
preincubated in the absence of DFP and in the presence of 2-
isopropanol (the organic solvent used to dissolve and store 
DFP) was used as a control. The percent residual activity 
compared to the control was determined at each time point. 
The log percent residual activity was then plotted as a 
function of time of preincubation. 
The concentration of DFP in the preincubation mixture 
was much greater than the concentration of the enzyme in 
each case. The reaction was therefore pseudo-first order 
and under these conditions, a plot of the log percent 
residual activity as a function of the time of preincubation 
was a straight line. The following equation was used to 
calculate the pseudo-first order rate constant (kobsd): 
ln 
where e 1 is the enzyme activity at time T1 and e2 is the 
enzyme activity at time T2 . The second order rate constant 
(expressed as M-1 sec-1) was obtained from kobsd-' where 
[I] 
[I] is the concentration of DFP (Powers, 1977). 
13. Molecular Weight Determination by High Performance 
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Gel Permeation Chromatography 
In determining the molecular weight of the enzyme by 
high performance gel permeation chromatography (Andrews, 
1965), a Toya Soda TSK-gel SW 3000 column was used. The 
column was equilibrated overnight in phos-EDTA-6. O buffer 
containing NaCl. Molecular weight determinations were made 
in the presence of either 0.05 M NaCl, 0.5 M NaCl, or 1.0 M 
. 
NaCl. In each case the column was run at 7. 2 ml/h and 
fractions were collected every 0.5 min. Fractions collected 
for the enzyme run were assayed for BAEE activity using the 
standard assay. Protein peaks were monitored at 214 nm and 
280 nm. The following proteins were run as standards: 
rabbit muscle aldolase (Mr= 158,000), bovine serum albumin 
(Mr = 68,000), ovalbumin (Mr = 45, 000) , B-amylase (Mr = 
200,000), glutamate dehydrogenase (Mr = 290,000) and 
ribonuclease (Mr= 13,700). 
14. Sodium Dodecyl Sulfate CSDS) Polyacrylamide Gel 
Electrophoresis 
Sodium dodecyl sulfate (SDS) gel electrophoresis was 
performed on the enzyme using the method of Laemmli (1970). 
A vertical discontinuous slab gel system was set up using an 
LKB vertical gel electrophoresis unit and an LKB high 
voltage power supply. The stock solutions needed for each 
of the gel components and the corresponding amounts used to 
prepare the gels is given in Appendix, Table A and Table B. 
Appendix, Table C details the buffers used for the 
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electrophoresis. The running gels (approx. 12 cm in length) 
contained 12. 5% polyacrylamide. These were overlaid by a 
spacer component (approx 3. 5 cm in length) containing 3% 
polyacrylamide. Enzyme samples (5-10 ug) were brought to 5 
M urea and 2% SDS (and also 2% 2-mercaptoethanol for samples 
to be electrophoresed under reducing conditions) and heated 
to 100° c for 5 min. A few microliters of bromophenol blue . 
dye solution were then added to the samples which were then 
layered into wells in the spacer gel. Electrophoresis was 
performed at room temperature at 10 ma per gel until the 
marker was 1 cm deep into the stacking gel. At this point 
the current was raised to 20 ma per gel and electrophoresis 
continued until dye had reached the lower edge of the gel. 
Gels were removed, and the migration distance of the dye was 
measured together with the length of the gel. They were 
then stained for 16 h in coomassie brilliant blue stain 
(0.1% coomassie blue, 50% methanol, 10% acetic acid). 
Destaining was done using several changes of a solution 
containing 7.5% acetic acid and 7.5% methanol. 
A series of molecular weight standards were also 
electrophoresed in the gels in order to determine the 
molecular weight of the enzyme. The standards were prepared 
for electrophoresis as described in sigma technical bulletin 
MWS-877 and brought to 6 M urea and 2% 2-mercaptoethanol and 
incubated at 37° C for 2 h. Aliquots were then stored at -
200 c and thawed for use. The Dalton Mark VII-L mixture 
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(Sigma) containing the following standards was used: bovine 
albumin (Mr= 66,000), egg albumin (Mr= 45,000), rabbit 
muscle glyceraldehyde-3-phosphate dehydrogenase (Mr = 
36,000), bovine erythrocyte carbonic anhydrase (Mr = 
29,000)' bovine pancreas PMSF-treated trypsinogen (Mr = 
24,000)' soybean trypsin inhibitor (Mr = 20,100), bovine 
milk lactalbumin (Mr = 14,200). The mobility of the enzyme 
and each standard in the gel was calculated as follows: 
mobility = distance of protein migration X 
length after destaining 
length before staining 
distance of dye migration. 
A plot of the mobilities as a function of log molecular 
weight was then used to determine the molecular weight of 
the enzyme. 
15. SDS Gel Electrophoresis of [~Hl-DFP-labelled 
Enzyme 
The enzyme was incubated with 25 uM (3H]-DFP at 250 
C in a total volume of 0.5 ml for 72 h in phos-EDTA-0.5 M-
NaCl-6.0. Complete inhibition was further ensured by the 
addition of 2 ul of 250 mM cold DFP. Removal of free (3HJ-
DFP was achieved by repeated dilution and filtration in a 
Centricon-30 microconcentrator unit. The enzyme was then 
subjected to SDS gel electrophoresis under both reducing and 
non-reducing conditions as described above. The gels were 
cut into 2 mm slices and each slice was placed into 0.3 ml 1 
N NaOH for 12 h. Each NaOH extract was then diluted with 
o.35 ml of 1 N HCl. 
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This solution was then added to 10 ml 
of scintillation fluid (Ecoscint) in a vial and counted in a 
Beckman Model LS-7500 liquid scintillation counter. 
16. Isoelectric Focusing On Polyacrylamide Gel 
Isoelectric focusing of the enzyme using an LKB 
Multiphor Flat Bed Electrophoresis Unit was carried out on 
precast polyacrylamide gels containing Ampholine carrier 
ampholytes. FAG-plates in the pH range 3.0 to 9.5 from LKB 
were used. The O. 5 mm gels were supported on a flat bed 
cooling plate maintained at 100 by an Lauda Thermostatic 
circulator. Glycerol was used to effect thermal contact 
between the gel and the cooling plate. The enzyme was 
concentrated in phos-EDTA-6. o buffer using a Centricon-30 
microconcentrator unit, and spotted on top of the gel away 
from either electrode in 10-15 ul aliquots. 1 M NaOH was 
used as the cathode solution and 1 M H3Po4 as the anode 
solution. The electrophoresis was carried out for 2 h with 
the following initial settings: voltage: 1500 V, current: 50 
mA, and power: 30 W. An LKB high voltage stabilized power 
supply was used. 
In order to ascertain the pI of the enzyme a mixture 
of proteins of known isoelectric points was spotted on the 
gel as described for the enzyme above and electrophoresed. 
A colored marker dye in this mixture served to monitor 
completion of migration of the standards and the enzyme. 
The migration distance of the dye from the cathode and the 
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length of the gel was recorded at the end of the experiment. 
The solutions used for fixing, staining, destaining and 
preserving the gel are described in Appendix, Table D. On 
completion of electrophoresis the PAG-plate was immediately 
placed in the fixing solution for 45 min, followed by 
destaining solution for 5 min. The gel was then stained 
with Coomassie brilliant blue staining solution preheated to 
60° c. It was then destained with several changes of the 
destaining solution. The destained gel was then placed in 
preserving solution for 1 h, removed, dried at room 
temperature and stored. 
The following standards of known pI were used in the 
experiment: amyloglucosidase (pI = 3.50), methyl red (pI = 
3.75), soybean trypsin inhibitor (pI = 4.55), B-lacto-
globulin A (pI = 5.13), bovine carbonic anhydrase B (pI = 
5.65), human carbonic anhydrase B (pI = 6.57), myoglobulin 
(pI = 6.76), L-lactic dehydrogenase (pI = 8.55) and 
trypsinogen (pI = 9.3). 
17. Active Site Titration 
A stock solution of MUGB ( 10 mM) dissolved in DMF 
was prepared for use to titrate an aliquot of the purified 
enzyme (Jameson et al., 1973). Enzyme was brought to 0.9 ml 
in phos-EDTA-7. 5 and O. 1 ml of the stock MUGB serially 
diluted in 0.001 N HCl to 0.1 mM was added to it to start 
the reaction. The release of the fluorescent methyl 
umbelliferone (MU) was monitorted on a Perkin Elmer MPF-44B 
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fluorescence spectrophotometer. The excitation wavelength 
was 365 nm and the emission wavelength was 445 nm. The 
percent fluorescence corresponding to the enzyme was equal 
to the intercept on the y-axis obtained by extrapolating the 
linear portion following the "burst" in fluorescence due to 
the enzyme, back to the axis on a plot of percent 
fluorescence as a function of time (Hartley & Kilby, 1954, 
Gutfreund, 1955, Schonbaum et al., 1961) A stock solution 
of a sodium salt of MU (50 uM) was also prepared in double 
distilled deionized H2o. The percent fluoresence of a series 
of dilutions of this stock was measured and plotted as a 
function of concentration. The concentration of the enzyme 
used for the experiment was then determined from this 
standard curve. The experiment was repeated for various 
concentrations of MUGB in the assay. 
18. Hydrolysis of Synthetic Substrates 
More than 20 tri- and tetra p-nitroanilide substrates 
were assayed for amidolytic activity with tryptidase using a 
Multistat rrrR centrifugal analyzer, in order to determine 
the specificity of the enzyme. An aliquot of enzyme was 
inserted in one chamber of each cuvette, in the 20 cuvette 
rotor, while phos-EDTA-7.5 buffer was inserted in the other 
cuvette together with each substrate. The final volume for 
each assay was 250 ul and concentration of the substrate in 
the assay was 1 mM. The rotor was first incubated at 300 
for a few seconds during which time the contents of the two 
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compartments of each cuvette were mixed by centrifugal 
force. Changes in absorbance were then immediately 
monitored at 405 nm at intervals of 0.5 min for a period of 
5. 5 min. Linear regression plots of the data were then 
obtained by use of a computer program and the change in 
absorbance per min for each substrate was determined from 
the slope of the curve. This quantity was then used to 
calculate the activity of the enzyme using the formula for 
amidase activity given above. 
Substrates which were most rapidly hydrolyzed by the 
pure enzyme were further used to assay the crude extract and 
the (NH 4 )2so 4 precipitation step described in the 
purification scheme, in order to find a more specific 
substrate for monitoring purification. The method followed 
for these latter assays is described in section 2b above. 
19. Hydrolysis of Larger Peptides 
The following larger peptides were assayed for 
cleavage by the enzyme. In each case, 10 mM stock solutions 
of the peptide were prepared in distilled deionized water. 
The peptide was then diluted in phos-EDTA-0.5 M-NaCl-7.5 to 
1 mM in a final assay volume of O .1 ml. Enzyme was added 
and the reaction was incubated at 25° for 16-18 h. At the 
end of this period the reaction was terminated by the 
addition of 30 ul of 10 mM heptane sulfonic acid-phosphate, 
pH 2.5. The volume was brought to a total of 0.213 ml with 
assay buff er. The mixture was then filtered through an 
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Amicon PM-30 membrane and the cleaved fragments detected by 
HPLC. Controls included 1) an aliquot of enzyme incubated 
in the assay buffer but in the absence of peptide, and 2) 
identical concentration of peptide in the assay buffer in 
the absence of enzyme. 
a. Vasopressin and Oxytocin 
A uBondapak c18 reversed-phase column (3. 9 mm x 30 
' cm) (10 um) and a Spectra Physics Model SP8700 solvent 
delivery system was used in order to separate cleaved 
products. The separation was performed isocratically using 
a mobile phase consisting of 0.1% trifluoroacetic acid (TFA) 
and acetonitrile in a ratio of 16: 84 for vasopressin and 
20:80 for oxytocin. Samples were injected by a Waters WISP 
Autosampler and the gradient flow rate was 1 ml/min. 
Peptides were detected using a UV absorbance monitor set at 
206 nm. The following standards were run: vasopressin and 
desglycinamide vasopressin in the case of vasopressin, and 
oxytocin and desglycinamide oxytocin in the case of 
oxytocin. 
b. Bradykinin 
In the case of bradykinin, a c18 Novapak, Radialpak 
cartridge (10 cm x 5 mm) (10 um) was used. Potential 
products were separated using a gradient between the 
equilibration buffer, 10 mM heptanesulfonate-phosphoric 
acid, pH 2.55 (A), and methanol (B) (Orawski et al., 1987). 
The gradient was developed as follows: O min-100% A, 10 min-
95% A, 65 min-40% A. 
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This system is capable of separating 
about 30 metabolites of bradykinin. 
20. Protein Degradation Studies 
The ability of the enzyme to cleave macromolecules 
was determined using casein, azocol, and haemoglobin. 
casein was assayed using the sensitive casein agar plate 
assay. The details of the procedure are described in the 
Biorad ~ulletin accompanying the Biorad protease detection 
kit. In the assays for azocol and haemoglobin, stock 
solutions of the protein substrates, buffers and reagents 
and assay techniques were as described in detail in 
Bergmeyer (1983). The latter procedures involved the 
incubation of the enzyme with a given protein substrate at 
25° for 30 min in potassium phosphate buffer pH 7.5. The 
mixture was then treated with trichloroacetic acid (TCA) 
(0.19 mM final concentration in the assay mixture) and 
thoroughly mixed. The precipitate was removed by 
centrifugation or filtration (Kunitz, 1947; Anson, 1938; 
Moore, 1969). The TCA soluble peptides were then measured 
by the method of Falin and Ciocalteu (1927). 
21. Kinetic Studies 
In order to determine the kinetic constants of the 
enzyme with respect to various substrates, each of the 
substrates in question was 
Spectrophotometer at its 
assayed on a Gilford Response 
characteristic wavelength as 
indicated above. Various concentrations of substrate (0.5 
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Km - 5 Km) were used and the change in absorbance over time 
was monitored. The initial velocities corresponding to each 
substrate concentration were then calculated by a built-in 
computer program on the spectrophotometer. Hanes-Woolf plots 
were then drawn for this data and the kinetic parameters 
determined using a computer program called Enzpak produced 
by Elsevier Publishing Co. (Hanes, 1932; Hanes et al., 
1972) . 
22. Partial N-Terminal Sequence of Tryptidase 
About 30 ug (based on Bradford protein assay) of pure 
enzyme was brought to doubly distilled deionized H2o by 
repeated filtration in a Centricon-30 microconcentrator 
unit. The sample was then passed through a O. 4 micron 
membrane filter and vacuum dried. Doubly distilled 
deionized H2o subjected to the same process with no enzyme 
was also prepared as a control. The amino terminal sequence 
of tryptidase through 25 residues was obtained through the 
courtesy of Applied Biosystems, Inc., Forest city, CA. The 
data was obtained by automated sequential Edman degradation 
using a 477A Pulsed Liquid Phase Protein/Peptide Sequencer. 
CHAPTER IV 
EXPERIMENTAL RESULTS 
A. Pilot Studies for Purification Scheme 
A number of pilot studies corresponding to possible 
steps in the purification scheme of tryptidase were done in 
order t9 set up optimal conditions for isolating the enzyme. 
1. Salt Extraction study 
The extractability of the BAEE activity from rat skin 
using two different concentrations of salt in neutral pH 
phos-EDTA buffer was studied. As can be seen from Table I 
no appreciable increase of BAEE activity occurred at 1.0 M 
NaCl in comparison with extraction in 0.5 M NaCl. Although 
a 1 M NaCl extraction had been used in our early work on 
tryptidase to determine some of the conditions for the 
purification scheme, the salt concentration used in the 
majority of the work reported here was therefore 0.5 M NaCl. 
Extraction of the enzyme in phos-EDTA-0.5 M-NaCl-pH 7.0 
constitutes the first major step in the purification of 
tryptidase from rat skin. The choice of the lower 
concentration of salt has the advantage of preventing the 
extraction of most of the ATEE activity as shown in Table I 
and also decreases the volume of extract that must be 
processed in the subsequent (NH4) 2 so4 step. 
2. Time Course of Extraction of BAEE Activity 
50 
51 
TABLE I 
EXTRACTABILITY OF BAEE AND ATEE ACTIVITY 
FROM RAT SKIN BY NaCl 
SUBSTRATE [NaCl] (M) ACT. (U/ml) 
BAEE 0.5 0.044 
1. 0 0.045 
ATEE 0.5 0.027 
1. 0 0.150 
Both BAEE and ATEE assays were done in duplicates on a 
Gilford Response spectrophotometer at 250 in an assay volume 
of 1 ml. Concentration for both substrates in the assay was· 
1 mM. Phos-EDTA-1 M NaCl pH 7. o was used as the assay 
buffer. Assays for ATEE were carried out at 237 nm. 
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Skin tissue is rich in mast cells. In the event that 
the enzyme of interest to this project could be from this 
source, it was important to determine whether the enzyme 
yields could be increased by allowing for the degranulation 
of the mast cells over time. Attempts were therefore made 
to monitor the release of BAEE and ATEE activity over time 
into the homogenate. Table II contains the results of such 
an experiment. Over a period of eight hours no appreciable 
increase in the yield of BAEE or ATEE activity was seen in a 
1 M NaCl extract. There was a 20% increase in BAEE activity 
but almost an 80% increase in ATEE activity over eight hours 
in the 0.5 M NaCl extract. It was therefore of advantage 
not to allow for any incubation period immediately after the 
homogenization step so that BAEE activity was not further 
contaminated by ATEE activity. 
3. Pilot Study for Ammonium Sulfate Precipitation 
With a view to concentrating down the BAEE activity 
and also achieving a measure of purification, a pilot 
ammonium sulfate study was undertaken. The results of such 
an experiment are portrayed in Figure 1. The overlap for 
the protein recovery curve and the BAEE activity recovery 
curve occurs at 40% and 70%. While these limits afforded an 
early practical starting point, the optimizing of 
recoveries, especially of activity in bulk studies, required 
extending the range to 25% to 80%. 
4. DEAE and CM Ion Exchange Chromatography 
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TABLE II 
TIME COURSE OF EXTRACTION OF BAEE AND ATEE ACTIVITY 
FROM RAT SKIN 
TIME (h) BAEE Units/ml ATEE Units/ml 
0.5 M NaCl 1 M NaCl 0.5 M NaCl 1 M NaCl 
0 0.044 0.045 0.027 0.150 
2 0.045 0.047 0.031 0.143 
4 0.046 0.052 0.037 0.148 
6 0.051 0.049 0.026 0.140 
8 0.054 0.048 0.046 0.132 
Both BAEE and ATEE assays were conducted in phos-EDTA-1 M · 
NaCl-7.0 buffer at 250 in 1 ml assay volumes on a Gilford 
Response spectrophotometer. Concentration for both 
substrates in the assay was 1 mM. Assays for ATEE were done 
at 237 nm. All assays were done in duplicate. 
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Figure 1. Pilot ammonium sulfate precipitation study. The 
experiment was performed using 50 ml aliquots 
of a 1 M NaCl, pH 7.0 extract filtered through a 
Buchner funnel to remove particulate matter. 
Aliquots were brought to 20, 40, 60, 70, 80 and 
90 percent ammonium sulfate (Taylor, 1953) and 
were allowed to sit overnight at 40. They were 
then centrifuged at 13,700 x g. The precipitate 
was resuspended in 25 ml phos-EDTA-6.0 buffer 
and assayed for BAEE activity (0) and protein 
(•) (Bradford, 1976). The activity and protein 
of the aliquot used for the experiment served as 
the control value. The % protein and % activity 
of the control were then plotted as a function 
f % ammonium sulfate. 
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Test tube studies (Pharmacia publication) were 
conducted on the BAEE activity to test the usefulness of ion 
exchange chromatography as a purification step. 
Precipitated enzyme from the 30-70% ammonium sulfate step 
was reconstituted in O. 5 M phosphate buffer, at either pH 
6.0, 6.5, 7.0, 7.5 or a.o. The data obtained (not shown) 
indicated that in experiments using DEAE A-50 ion exchange 
medium, 'over 90% of the BAEE activity adsorbed at pH 7. 5. 
When CM-Sephadex A-50 chromatography medium was tested using 
acetate buffers at either pH 4.0, 4.5, 
adsorption occurred at pH 5.0. However, 
5 or 5. 5, maximum 
it was also found 
that about 50% of the BAEE activity was lost in converting 
to pH 5. O before application to the medium. While ion 
exchange chromatography conditions were established at pH 
6.0 for bulk experiments using a combination of DEAE and CM-
Sephadex, the technique had the following disadvantages: a) 
the step necessitated the conversion of the enzyme 
preparation to a no NaCl state which resulted in significant 
loss of BAEE activity, b) equilibration, application, 
elution and reconcentration of eluent required an average of 
two days. Since a later experiment showed that it was 
possible to go to a specific affinity step directly, no 
further use was made of ion exchange chromatography in the 
final purification scheme proposed. 
5. Agarose-Glycyl-Glycyl-p-Aminobenzamidine Affinity 
Chromatography Pilot Study 
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since our initial goal was to purify a 
carboxamidopeptidase-like enzyme from rat skin, the p-amino-
benzamidine-CH-Sepharose (PAB-CH-Sepharose) affinity column 
was tried using conditions described by Simmons & Walter 
( 1981) . However, while 34% of the activity from a previous 
ion exchange step adsorbed to the column, it was not 
possible to elute activity using 50 mM D-tryptophan methyl 
. 
ester as described for the toad enzyme by the authors above. 
Commercially available agarose-glycyl-glycyl-p-amino-
benzamidine (A-Gly-Gly-PAB) (p-aminobenzamidine attached to 
agarose through a glycyl glycine spacer arm) was then 
obtained. It was decided to try benzamidine in the elution 
buffer to recover BAEE activity that adsorbed to this 
column. When initial results proved encouraging using 0.2 M 
benzamidine, a systematic study was conducted to optimize 
conditions. Table III indicates that while the overall 
recovery for this step is independent of the temperature at 
which the experiment is performed, temperature does have a 
significant impact on the purification achieved. The 
purification factor using room temperature is nearly 10-fold 
higher than that performed under identical conditions at 4°. 
The pH conditions are also seen to be an important factor in 
achieving better purifications. The purification achieved 
at pH 6.0 is nearly double that achieved at pH 7.0 when the 
experiment is performed at room temperatures. However at 4° 
the opposite trend is in effect, with the purification 
6.0 
6.0 
7.0 
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TABLE III 
AGAROSE-GLY-GLY-PAB AFFINITY COLUMN 
TEMP. 
RT 
RT 
PILOT STUDY 
SP. ACT.b 
OF ELUTED ENZYME 
(U/MG) 
3.84 
42.8 
4.38 
20.2 
PURIF. % APPLIED 
FACTOR ENZYME 
ELUTED 
48.1 27 
521 20 
62.4 28 
311 22 
aEnzyme was brought to the corresponding pH before 
application to the column at either pH. The buffer used at 
each pH was Phos-EDTA-0.5 M NaCl. 
bBAEE activity and the Bradford protein assay were used to · 
calculate the specific activity. 
The enzyme was eluted with 0.1 M benzamidine in the 
application buffer. Fractions containing BAEE activity were 
pooled and benzamidine was removed by ultrafiltration 
through a PM-30 Amicon membrane before estimation of BAEE 
activity. 
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factor being about 50% higher. 
Based on this pilot study it was decided to purify 
the enzyme using A-Gly-Gly-PAB specific affinity 
chromatography at pH 6. O and room temperature. While the 
column is maintained at room temperature, the enzyme 
reservoir is kept on an ice bath to prevent proteolytic loss 
or temperature denaturation of the BAEE activity before 
I adsorption to the column. Collection of eluent fractions 
was also done at 40 for the same reasons. 
Application of the reconstituted dialyzed ammonium 
sulfate precipitate directly to the column did not reduce 
the degree of purification achieved or the overall recovery 
of the enzyme. This made it possible to skip the ion 
exchange step. 
6. Concanavalin-A Agarose Affinity Chromatography 
Since carboxamidopeptidase from toad skin (Simmons & 
Walter, 1981) was known to be a glycoprotein, and our 
original focus was to identify and isolate this enzyme in 
rat skin, concanavalin-A agarose affinity chromatography was 
tried on the BAEE activity eluted from the A-Gly-Gly-PAB 
column. Adsorption of the enzyme to the column was achieved 
in 25mM phosphate buffer at pH 6.0 in the presence of 0.5 M 
NaCl. The enzyme was eluted with the same buffer containing 
100 mg/ml o<-methyl-D-mannoside . 
B. Final Purification Scheme 
A final purification scheme utilizing the information 
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derived from numerous pilot studies, some of which were 
discussed above, was developed which could yield an enzyme 
preparation which was homogeneous. The procedure is 
outlined in the flow chart given in Table IV. The 
purification of the enzyme is achieved in just two major 
steps. Following homogenization of the skin tissue, the 
first major step consists of the 25-80% ammonium sulfate 
precipitation followed by dialysis. The second major step 
is specific affinity chromatography utilizing two sequential 
columns of different specificity. The first column is the 
A-Gly-Gly-PAB column which has affinity for the active site 
of tryptidase and the second column is con A-agarose which 
binds carbohydrate moieties attached to the enzyme. Since 
the specific affinities of the two columns are directed to 
different parts of the enzyme molecule, it was possible to 
couple the two columns as indicated in Table IV. The 1 mM 
EDTA which was added to the buffers in the earlier part of 
the purification scheme was eliminated, since EDTA would 
remove the calcium and magnesium ions required for the 
binding properties of concanavalin A. NaN3 (0.02%) was used 
instead as a bacteriostatic agent in the column buffers. 
1. Purification of Tryptidase 
Results of two representative purifications of 
tryptidase are expressed in Tables V and VI and are based on 
BAEE activity rather than on activity of more specific 
substrates (see below) . 
TABLE IV 
PURIFICATION SCHEME FOR TRYPTIDASE 
I. TISSUE PREPARATION AND HOMOGENIZATION 
a. Removal of fur, muscle tissue and fatty layer, 
and fascia 
b. Mincing: twice through # 3 meat grinder 
c. Homogenization in phos-EDTA-0.5 M NaCl-7.0 
(1:9 v/v) 
d. Filtration through nylon mesh and Buchner 
funnel under vacuum 
II. 25-80% (NH4)2S04 PRECIPITATION 
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a. Filtrate brought to 25% (NH4 ) 2so4 , allowed to 
sit for 4-6 hand centrifuged at 13,700 x g. 
b. Supernatant brought to 80% (NH4 ) 2so4 , left 
unstirred for 14-16 h and then centrifuged as 
above. 
c. Reconstitution of 80% ppt. in phos-EDTA-0.5 M 
NaCl-6.0 
d. Dialysis against reconstitution buffer 
e. Centrifugation of dialysate. supernatant 
saved. 
III. SPECIFIC AFFINITY CHROMATOGRAPHY 
a. Application of sample to Gly-Gly-PAB-agarose 
column at RT followed by wash with 
equilibration buffer. 
b. Equilibration of column to 4o followed by a 
2nd wash and finally elution with phos-NaN3-
0. 5 M NaCl-6.0 containing 0.1 M benzamidine. 
c. Eluent pumped onto concanavalin A-agarose 
column 
d. Columns disconnected and concanavalin A column 
washed with phos-NaN3-o.5 M NaCl-6.0, followed 
by elution with the same buffer containing 100 
mg/ml«-methyl-D-mannoside. 
IV. CONCENTRATION AND STORAGE OF ENZYME 
a. Conversion to phos-EDTA-0.5 M NaCl-6.0 in 
Amicon microconcentrators. 
b. Storage at 4°. 
TABLE V 
P U R I F I C A T I 0 N 0 F T R Y P T I D A S E B A S E D 0 N 8 A E E A C T I V I T Y 
Treatment 
1 3 , 7 0 0 x g 
Supernatant 
2 5 . 8 0 x Amon 
s u l f • pp t . 
G l y • G l y · P A B ; 
Con A A t t i n . 
T o t a l 
Activity (U) 8 
252 
1 4 0 
1 5 . 8 
T o t a l 
Protein (mg)b 
5460 
2 1 6 0 
0 . 1 4 
8 All a111y1 were performed at 25° c. 
Specific 
A c t • ( U I m g ) 
0 • 0 4 6 
0 • 0 6 5 
1 1 7 • 0 
baradford mlcroassay was used to estimate protein. 
Percent 
Recovery 
1 0 0 
5 5 • 6 
6 • 3 
P u r i f i c a t i o n 
F a c t o r 
1 • 4 
2550 
TABLE VI 
P U R I F I C A T I 0 N 0 F T R Y P T I D A S E B A S E D 0 N B A E E A C T I V I T Y 
Treatment T o t a l T o t a l S p e c i f i c 
A c t i v i t y ( U ) a Protein (mg)b A c t • ( U I m g > 
1 3 I 1 0 0 x g 1 5 3 3320 0. 0 4 6 
Supernatant 
2 5 . 8 0 x A m o n 8 6 • 8 1 5 0 0 0 • 0 5 8 
s u l f • p p t • 
G l y · G l y · P A B ; 1 2 • 1 0. 0 7 3 1 6 6 
Con " A f f i n • 
8 A l l a s s a y s w e r e p e r f o r m e d a t 2 5 ° C • 
beradford microassay was used to estimate protein. 
Percent 
Recovery 
1 0 0 
5 6 • 8 
1. 9 
P u r i f i c a t i o n 
F e c t o r 
1 • 3 
3 6 1 0 
O'I 
w 
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a. (NH41 2so4 Fractionation 
A significant proportion of the BAEE activity is lost 
in the 25-80% ammonium sulfate precipitation step. The loss 
seems to occur mainly in the 80% step since the 25% 
supernatant was seen to repeatedly contain 85-90% of the 
original activity. No significant purification is achieved 
in this step. However, it does serve to eliminate over 50% 
of the ' contaminating protein and results in significant 
concentration of the enzyme which is required for the 
subsequent steps. 
b. Specific Affinity Chromatography 
i. A-Gly-Gly-PAB-Chromatography 
The affinity of tryptidase for the A-Gly-Gly-PAB-
column is demonstrated 2. The bulk of 
contaminating protein 
activity flowed through 
as 
in Figure 
well as 
the column 
non-tryptidase BAEE 
when a concentrated 
enzyme solution from a previous step was applied in phos-
EDTA-0. 5 M-NaCl-6.0 buffer. Only about 20-30% of the 
applied BAEE activity bound to the column. Most of the 
adsorbed activity could be eluted with 0.1 M benzamidine. 
In Figure 2, the eluted enzyme was collected in fractions 
and assayed to give a complete chromatogram. Normally, 
however, the eluted enzyme was pumped directly onto the con 
A-agarose column. 
ii. Concanavalin-A-Agarose Chromatography 
When enzyme solution from the A-Gly-Gly-PAB column 
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Figure 2. Agarose-Glycyl-Glycyl-p-Aminobenzamidine 
chromatography. 
Enzyme from the previous purification step was 
applied at a flow rate of 25 ml/h to a 1.5 x 20 
cm agarose-glycyl-glycyl-p-aminobenzamidine 
column equilibrated with phos-EDTA-0.5 M NaCl-
6.0 and 1 ml fractions were collected. The 
enzyme reservoir was maintained at 40c on an 
icebath and while the column itself was kept at 
room temperature. After application of the 
enzyme, the column was washed with 1.5 column 
volumes of the equilibration buffer. The enzyme 
was then eluted with the same buffer containing 
0.1 M benzamidine.HCl and 1 ml fractions were 
collected. Protein (Bradford, 1976) (0); BAEE 
activity (•). 
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was concentrated and then applied to a con A-agarose column 
in 2 5 mM phos-0. 5 M-NaCl-6. O, the majority of the BAEE 
activity was retained on the column while inactive protein 
eluted in the breakthrough peak (Figure 3). Upon applying 
100 mg/ml of «-methyl-D-mannoside in equilibration buffer to 
the column, tryptidase was eluted in an initial sharp peak 
followed by some trailing. 
The overall purification achieved in this two step 
purification, based on BAEE activity, is in the range 2500 
to 3600 with overall recoveries ranging from 6% to 9%. 
c. Purification Based on Correction for Non-tryptidase 
BAEE activity 
Mention was made above of the fact that the bulk of 
BAEE activity passed through the A-Gly-Gly-PAB column. In 
order to ascertain that this effect was not due to 
overloading of the column, the A-Gly-Gly-PAB column was 
subjected to the routine cleaning procedure consisting of 
two column volumes of phos-EDTA-0.5 M-NaCl-6.0 buffer 
containing 8 M urea followed by at least four column volumes 
of the buff er with out urea. The pooled breakthrough was 
then applied to the column using conditions identical to 
those for the original enzyme solution application. 
Fractions were collected and assayed for BAEE activity. It 
was found that no adsorption of activity to the column 
occurred. All of the activity could be accounted for in the 
breakthrough. Furthermore, benzamidine failed to elute any 
68 
Figure 3. Concanavalin A-agarose chromatography. The 
enzyme preparation from the agarose-glycyl-
glycyl-p-aminobenzamidine chromatography step 
was concentrated and applied at a flow rate of 
10 ml/h to a 0.75 x 10 cm concanavalin A-
agarose column equilibrated in 25 mM phosphate-
0. 5 M NaCl-pH 6.0 buffer, and 1 ml fractions 
were collected. The column was then washed with 
1 column volume of the equilibration buffer and 
eluted in the same buffer containing 100 mg/ml 
~-methyl-D-mannoside. The flow rate was 
decreased to 5 ml/h. After passing through 1 
column volume of the elution buffer, the flow 
was stopped and the column was allowed to 
incubate for 1 h. Elution was then continued. 
The entire experiment was carried out at 40 c. 
Protein (Bradford, 1976) (0); BAEE activity (•). 
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additional activity from the column. 
Since the breakthrough of the A-Gly-Gly-PAB column 
contains non-tryptidase BAEE activity, the results shown in 
Table VII are reconfigured to reflect this. In this table, 
the breakthrough BAEE activity from the A-Gly-Gly-PAB column 
is subtracted from the values for both the 13, 600 x g 
supernatant and the ammonium sulfate precipitation steps to 
give activity values which more nearly approximate the 
actual tryptidase activity present at the end of the two 
steps. When the calculations are redone using such an 
approach, the enzyme is seen to be purified 6900-fold with a 
recovery of nearly 16%. 
d. Purification Based on More Selective synthetic 
Substrates 
The experiments described above made it apparent that 
the homogenate from rat skin contained more than one BAEE 
hydrolyzing enzyme. In order to monitor the purification of 
tryptidase more accurately a more selective substrate was 
necessary. Several different peptidyl-p-nitroanilides were 
therefore tested as potential substrates using a purified 
preparation of the enzyme. A number of these p-
nitroanilides were observed to be hydrolyzed. Aliquots from 
each step of one purification were then assayed for their 
ability to cleave 20 of these peptides. Of these, the nine 
listed in Table VIII held promise as selective substrates 
for tryptidase. All nine yielded final recoveries for the 
T r e • t 111 e n t 
13,700 x g 
Supernatant 
25·80X Amon 
s u l f. pp t. 
G l y • G l y • P A B ; 
Con A A ff in. 
TABLE VII 
. 
PURIFICATION OF TRYPTIDASE BASED ON BAEE 
AND CORRECTED FOR BREAKTHROUGH ACTIVITY 
Total Total 
A c t i v i t y ( U ) • ' c P r o t e i n ( m g ) b 
77.8 3320 
1 1 • 7 1 5 0 0 
1 2 . 1 0. 0 7 3 
s p e c i f i c 
A c t • ( U I m g ) 
0 • 0 2 4 
0,. 0 0 8 
166 
Percent 
Recovery 
1 0 0 
1 5 • 1 
1 5 • 6 
8 All essays were performed et 25° c. 
beredford microassey was used to estimate proteins. 
p u r i f 'i c a t i o n 
F a c t o r 
0 • 3 
6920 
c A c t i v i t Y r e f l e c t s b r e a k t h r o u g h a c t i v i t y s u b t r e c t e d f r o m t o t a l a c t i v i t y m e a s u r e d • 
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TABLE VIII 
SELECTIVE SUBSTRATES FOR MONITORING 
PURIFICATION OF TRYPTIDASE 
SUBSTRATE TOTAL ACTIVITY (Units)g~~~ % RE-
COVERY 
Pure (overall) 
13,700 x g 
Supernatant 80% Ppt. 
S-2238 153 79.3 36.4 23.8 
S-2251 69.76 10.94 5.3 7.6 
S-2266 151. 88 36.5 13.0 8.6 
S-2288 418.26 205.7 90.0 21. 5 
S-2444 164.2 72.4 32.1 19.6 
Chromozym Try 49.3 14.8 8.1 16.5 
Chromozym p 199.97 96.9 43.6 21. 8 
Spectrozyme 270.8 145.37 77.6 28.7 
Ca 
S-2222 98.7 51. 8 21.8 22.04 
Assays were performed in a Gilford Response spectrophoto-
meter at 405 nM at 25°, and were run for 1 min. 
S-2238, S-2251, S-2266, S-2288 and S-2222 were lmM in the 
assay, while S-2444, Spectrozyme Ca, and Chromozym P was 0.5 
mM and Chromozym Try was 0.25 mM. 
S-2238 = H-D-Phe-pip-Arg-pNA; S-2251 = H-D-Val-Leu-Lys-pNA; 
S-2266 = H-D-Val-Leu-Arg-pNA; S-2288 = H-D-Ile-Pro-Arg-pNA; 
S-2444 = Pyro-Glu-Gly-Arg-pNA; Chromozym Try = H-D-Val-Gly-
Arg-pNA; Chromozym PL = Tos-Gly-Pro-Lys-pNA; Spectrozyme Ca 
= H-D-Pro-Pro-Arg-pNA; S-2222 = Bz-Ile-Glu-(-0-R)Gly-Arg-
pNA. R = CH3 or H 
aEach value is a mean of duplicate assays. 
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enzyme that were better than when BAEE was used as a 
substrate. Three of the substrates, S-2238, S-2288 and 
Chromozym PL, as well as Spectrozyme Pea, were then selected 
for monitoring two additional tryptidase purifications. The 
data is shown in Tables IX and X. Chromozym PL, and S-2288 
yielded the highest recoveries and purification factors. 
Both were more selective than S-2238, since the breakthrough 
from the A-Gly-Gly-PAB column contained less than 10% of the 
activity put on with respect to Chromozym PL and S-2288 but 
over 35% with respect to S-2238. This is also reflected in 
the final recoveries and purification factors for each of 
them. The mean recovery from the two enzyme preparations 
based on Chromozym PL 29%, while S-2288 gave 35% and s-
2238, 22%. The average of purification factor for Chromozym 
PL was 10,600, for S-2288, 12,400 and for S-2238, 8000. By 
comparison BAEE gave 7% recovery and only 3080-fold 
purification (mean based on Tables V and VI). 
The results using Spectrozyme Pea in both tables are 
disappointing when compared with the results for Spectrozyme 
Ca shown in Table VIII. The reason for the disparity in 
results is evident from the fact that the two substrates 
have somewhat different sequences. The sequence for 
Spectrozyme Ca is H-D-Pro-Pro-Arg-pNA while that for 
Spectrozyme PCa is Tos-Lys-(Cbo) -Pro-Arg-pNA. It was not 
possible to obtain additional quantities of Spectrozyme Ca 
because the manufacturer had substituted it with Spectrozyme 
TAILE IX 
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Tre•t••nt Subetrete Total Tot• I Specific Percent 
Activity <U> 8 Proteln <••>b Act • (U/•8) Recovery 
, 3. 7 0 0 • • Chro•o. PLC 142 3320 0. 0 4 3 100 
Supernetent 
Spec. PCed 1000 0. 3 0 3 
I• 2 2 II e 340 0., 0 2 
1·2231 1 326 0.099 
2 s ·a o" A•on Chro•o. p L as. s 1500 0. 0 5 7 6 0. J 
s u l f • pp t. 
Spec. PC a 314 0. 2 0 9 3 1. J 
s. 2 2 •• 19 7 0. 1] 1 s a. o 
s. 2231 227 0. 151 69.6 
Gly·Gly·PAI; Chro•o. PL 11. a 0. 0 73 5 18 2 6. 6 
Con A A ff in. 
Spec. PCe 68. 0 ,9 3 2 6. a 
1·2288 95. 7 131 0 2 a. 1 
1·2238 61. 8 847 18. 9 
aAll assays were performed at 250 in a Gilford Response spectrophotome!ter 
hsradford microassay was used to estimate proteins. 
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fs-2238 = H-D-Phe-pip-Arg-pNA 
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s-2299e 
S·2238f 
Chro•o. PL 
Spec. PC• 
5·2288 
s. 2238 
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Spec. PC• 
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e. Purity of Tryptidase 
In order to determine the purity of the tryptidase 
obtained through the purification scheme described, some of 
the enzyme was subjected to SDS polyacrylamide gel 
electrophoresis in 12. 5% gels according to the method of 
Laemmli (1970). Figure 4 shows a single band for tryptidase 
. 
under both reducing (lane A) and non-reducing (lane B) 
conditions. Visualization of the gels was achieved by 
coomassie brilliant blue staining. 
Inhibitor studies had shown that the enzyme was 
inactivated by DFP. The enzyme was therefore labelled with 
[ 3HJ-DFP and then subjected to SDS electrophoresis as 
described in METHODS. The gels were dissected into 2 mm 
sections which were then processed as described in METHODS 
to release the radioactive label and counted using a liquid 
scintillation counter. Figure 5 shows that the peak of 
radioactivity corresponded with the single protein band seen 
by Coomassie brilliant blue staining. The results indicate 
therefore that the stained band is, in fact, tryptidase and 
that the purification scheme therefore results in apparently 
homogeneous enzyme as determined by this technique. 
Symmetrical single protein peaks (A214) were also seen when 
tryptidase was subjected to analytical high performance gel 
permeation chromatography using both low and high salt 
conditions (see below) . This is further corroboration of 
Figure 4. Determination of purity and molecular weight of 
tryptidase by SOS gel electrophoresis. The 
enzyme was electrophoresed in SOS polyacrylamide 
gels under both reducing (lane A) and non-
reducing (lane B) conditions as described 
in METHODS. Molecular weight markers were a) 
bovine albumin, b) egg albumin, c) glyceral-
dehyde-3-phosphate dehydrogenase, d) carbonic 
anhydrase, e) trypsinogen, f) soybean trypsin 
inhibitor and g) «-lactalbumin. The mobility 
of the markers was calculated as described in 
METHODS and plotted against their corresponding 
log molecular weight to generate a standard curve. 
Figure 5. Sodium dodecyl sulfate (SDS) polyacrylamide gel 
electrophoresis of radiolabeled tryptidase. SDS 
gel electrophoresis was performed as described in 
METHODS using non-reducing conditions. 3H-DFP 
was used to prelabel the enzyme. Gels were 
stained for protein using Coomassie brilliant 
blue. The gel was then cut into 2 mm sections, 
extracted as described in METHODS, and counted 
for radioactivity. 
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the apparent homogeneity of the enzyme. When the enzyme was 
recently subjected to microbore reversed phase HPLC in 
preparation for N-terminal sequencing, two peaks were 
detected. Since the concanavalin A affinity of the enzyme 
establishes its glycoprotein nature, the two peaks possibly 
differ with respect to their carbohydrate moieties. The 
microheterogeneity detected during isoelectric focussing of 
the enz:Yme supports such a view (see below). When a mixture 
of the two peaks were sequenced to identify the first 25 
amino acids of the N-terminal of the enzyme, a homologous 
sequence was obtained, substantiating that the two peaks 
corresponded to one and the same enzyme, and verifies the 
homogeneity of the tryptidase purified. 
2. Storage Conditions for Tryptidase 
The purified enzyme is stable for prolonged periods 
of time extending over six months in phos-EDTA-0.5 M-NaCl-
6. o at 4 O. One attempt to preserve the enzyme at 4 O in 
phosphate-EDTA buffer at neutral pH without NaCl proved 
costly, since the preparation assayed after three months had 
lost more than 50% of its activity. On other occasions when 
experiments with tryptidase required the elimination of salt 
from the preparation, even overnight storage of the enzyme 
without NaCl at pH 6.0 was found to result in severe losses 
of activity. SDS gel electrophoresis failed to reveal any 
autolysis fragments, al though the system was incapable of 
detecting molecular weight fragments smaller than 11, 000 
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daltons. A significant band was seen corresponding to that 
for active enzyme and may indicate that the enzyme undergoes 
slow denaturation without autolysis. 
Tryptidase also proved to be stable at room 
temperature in phos-EDTA-0.5 M-NaCl-6.0 buffer in tests done 
for time periods ranging up to eight days. The enzyme can 
also survive freezing at -20°. In fact repeated freezing 
and thawing of the enzyme through six 24 h cycles had no 
significant effect on the activity of the enzyme. 
Table XI presents the results of some of the other 
storage conditions tried on the enzyme. The higher 
activities seen on day 1 compared to day o presumably 
represent more complete reconstitution of dried enzyme by 
day 1. Vacuum drying in the presence of 2% 20 M Carbowax 
using a Savant Speed-vac concentrator resulted in survival 
of approximately 80% activity in contrast to lyophilization 
where only 51% survived. The vacuum dried enzyme was just 
as stable at room temperature as at 40. Tryptidase seems to 
survive freezing at -10° since up to 80% of activity was 
recovered after freezing in an acetone-dry ice bath. 
3. Effect of NaCl on Tryptidase Activity 
Although NaCl was seen to be important for the long 
term storage of tryptidase, Figure 6 suggests that its 
presence is not required for optimal BAEE activity of the 
enzyme. Concentrations of up to 1 M NaCl in the standard 
assay buffer had no apparent effect on activity. 
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TABLE XI 
EFFECT OF STORAGE CONDITIONS ON 
PURIFIED TRYPTIDASE 
STORAGE CONDITION % RECOVERY 
DAY 0 DAY 1 
Vacuum dried stored at RT 48 81 
Vacuum dried stored at 40 61 78 
Lyophilized 44 51 
Dry ice-acetone Frozen 80 78 
Stored at -200 100 112 
The BAEE activity of the original aliquot of enzyme put into 
storage was used as the 100% control. All assays for 
activity were performed in triplicate. Enzyme stored in· 
phos-EDTA-0.5 M NaCl-6.0 was used in each experiment. 
Reconstitution was achieved in distilled deionized H2o. 
Dry ice-acetone bath frozen sample preserved at 40 was used 
as the control for the lyophilized sample. 
Figure 6. Effect of NaCl on BAEE activity. The enzyme was 
assayed for BAEE activity for 15 min at 250 in 
0.1 M phosphate buffer, pH 7.5, containing 
concentrations of NaCl ranging from no NaCl to 1 
M NaCl. Concentration of BAEE in the assay was 
1 mM. A plot of % maximum activity vs. NaCl 
concentration was drawn. 
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consequently, it was decided not to use any NaCl in the 
standard buffer. It may be noted that the concentration of 
substrate used was 1 mM. In the light of later results 
showing that the Km for BAEE is 0.0128 mM, 1 mM BAEE may be 
masking any effect of the NaCl on Km· 
4. pH stability 
The effect of preincubating the enzyme at various 
pH's for 2 h at 250 is seen in Figure 7. Tryptidase is at 
least partially stable over the pH range 3. 5 to 7. 5 but 
retains virtually no activity following preincubation at 
pH's below 3. O or above 8. o. The enzyme demonstrated 
maximal stability in the pH range 5.5 to 7.5. 
5 . pH Optimum 
Studies on tryptidase to determine its pH optimum for 
BAEE activity showed that the enzyme has optimal activity in 
the range pH 7.0-8.0 (Figure 8). Activity dropped rapidly 
at pH's below 6.0 even though the enzyme is stable at low 
pH's. Severe loss of activity was also observed at pH's of 
8.5 and above. The loss of activity at the higher pH's is 
explainable in part by the instability of the enzyme at 
these pH's (Figure 7). Since maximum activity was observed 
at pH 7. 5 in phosphate buffer, these conditions were used 
for the standard assay. No loss of activity was discernable 
over the routine 5-15 min assay period using these assay 
conditions. 
6. Temperature Stability at pH 7.5 
s7 
Figure 7. pH stability. An aliquot of enzyme was 
preincubated in different 0.1 M buffers at 250 
for 2 h in a 0.1 ml volume. The mixture was 
then assayed in the preincubation cuvette for 
BAEE activity using the standard assay. 
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Figure 8. pH optimum. An aliquot of enzyme was assayed 
for BAEE activity in different 0.1 M buffers 
as described in METHODS. 
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The effect of temperature on tryptidase stability at 
pH 7.5 is shown in Figure 9. 
activity is irreversibly 
preincubated for 30 min at 
Half of the enzyme's maximum 
lost when the enzyme is 
300. The enzyme is rapidly 
inactivated when preincubated for 30 min at temperatures 
above 35°. Thus tryptidase is quite heat labile at pH 7.5. 
Routine assays were therefore done at 25° for time periods 
not exceeding 15 mins to keep the temperature effects to a 
minimum. It is possible that the enzyme may be more heat 
stable at lower pH's where it is more pH stable (see Figure 
7) • 
7. Effect of Protease Inhibitors on Tryptidase 
Activity. 
A number of natural protein protease inhibitors were 
screened in order to determine their effect on tryptidase. 
It is evident from Table XII that Trasylol (basic pancreatic 
trypsin inhibitor, 
protein trypsin 
bovine) is the only one of the large 
inhibitors to inhibit tryptidase. 
Significantly, no inhibitory effect was seen with 
concanavalin A. Although the enzyme can be purified using 
concanavalin A-agarose chromatography, the results suggest 
that the binding of concanavalin A does not result in a 
conformational change or steric hindrance sufficient to 
prevent accessibility of the active site to the BAEE 
substrate. Hirudin, an inhibitor of thrombin extracted from 
leeches, had no effect on tryptidase at 1 unit/ml. 
Figure 9. Temperature stability at pH 7.5. An aliquot of 
enzyme was preincubated in phos-EDTA-7.5 at 
various temperatures for 30 min. in 0.1 ml 
volume. The entire mixture was then assayed in 
the preincubation cuvette for BAEE activity at 250. 
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TABLE XII 
EFFECT OF PROTEINASE INHIBITORS ON TRYPTIDASE ACTIVITY 
Inhibitor Concentration 
mg/ml 
Percent 
Inhibition 
Trasylol (basic pancreatic trypsin 0.1 94 
inhibitor) 
Lima Bean Trypsin Inhibitor 1.0 o 
Ovomucoid 1.0 o 
Soybean Trypsin Inhibitor (Kunitz) 1.0 o 
ot1-Antitrypsin 1.0 o 
Concanavalin A 1.oa,b o 
Hirudin 1.0 unit/mla O 
NPGB (p-nitrophenyl-p'-guanidino- 10.0 (uM)a 100 
benzoate) 
MUGB (p-methylumbelliferyl-p'- 10.0 (uM)a 99 
guanidinobenzoate) 
Enzyme and inhibitor were preincubated for 5 min at 25° C 
and pH 7.5. Reaction was started by addition of BAEE to 1 
mM. All assays were performed in triplicate. 
aconcentration in final assay. 
bpreincubation volume was 0.9 ml. 
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Two of the other inhibitors in Table XII which were 
effective inhibitors of tryptidase were p-nitrophenyl-p' -
guanidinobenzoate (NPGB) and 4-methyl-umbelliferyl-p'-
guanidinobenzoate (MUGB). Both were able to cause complete 
inhibition at 10 uM. When MUGB (50 nM) was tested as a 
potential substrate for the enzyme using a fluorometric 
assay no turnover of the enzyme was seen at pH 7.5 over a 5 
min period following the initial "burst" indicating that the 
substrate binds irreversibly to the enzyme. 
Table XIII shows the effect of several microbial 
proteinase inhibitors (Umezawa and Ayogi, 1977) on 
tryptidase. Antipain and leupeptin were the best inhibitors 
of this class causing 80% inhibition at 50 ug/ml. The 
chymotrypsin inhibitor failed to inhibit the enzyme at 100 
ug/ml as did elastatinal (the elastase inhibitor), pepstatin 
A and bestatin at concentrations as high as 200 ug/ml. 
8. Effect of Chemical Modification Reagents 
Among the inhibitors that act by chemically modifying 
the enzyme, diisopropylphosphofluoridate (DFP) inhibited 
tryptidase 93% at lmM when preincubated with the enzyme for 
10 min at 250 and pH 7.5 (Table XIV). Essentially complete 
inhibition could be achieved under identical conditions in 
30 min. Tos-Lys-cH2Cl which is known to act by alkylating 
the active site histidine of trypsin was an effective 
inhibitor of the enzyme. Significantly less inhibition was 
seen for Tos-Phe-CH2Cl (22%) and Z-Phe-CH2Cl (10%), both of 
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TABLE XIII 
EFFEC~ OF MICROBIAL PROTEINASE INHIBITORS ON TRYPTIDASE 
Inhibitor 
Anti pain 
Leupeptin 
Chymostatin 
Elastatinal 
Peps ta tin Ab 
Bestatinb 
Concentration 
ug/ml 
50 
50 
100 
200 
50 
200 
200 
Percent a 
Inhibition 
80 
79 
0 
4 
3 
0 
0 
ainhibition measured at pH 7. 5 using BAEE as substrate. 
Final concentration of the substrate in the assay was 1 mM. 
All assays were done in triplicate. 
bcontrol and inhibitor assay contained 10% methanol. 
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TABLE XIV 
EFFECT OF CHEMICAL MODIFICATION REAGENTS ON 
TRYPTIDASE ACTIVITY 
Reagent 
DFPa 
Tos-Lys-CH2c1a 
Tos-Phe-CH2c1a,b 
Z-Phe-CH2c1a,c 
p-CMBa 
DTTd 
2-Mercaptoethanold 
€-Aminocaproic Acidd 
E-64a 
Concentration 
(mM) 
1. 0 
1. 0 
1. 0 
0.2 
0.05 
10.oe 
10.oe 
l.Oe 
10.0 (uM) 
Percent 
Inhibition 
93 
54 
22 
10 
85 
0 
0 
11 
0 
aEnzyme was preincubated with test reagent for 10 min at 25° 
c and pH 7. 5 The entire aliquot was then assayed for 
residual activity using BAEE as a substrate and compared to 
control sample preincubated in the absence of reagent. 
bPreincubation mixture contained 20% methanol (v/v). 
cPreincubation mixture and control contained 10% DMSO (v/v). 
dpreincubation was for 5 min. 
econcentration in final assay. 
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which are known to act by a similar mechanism against 
chymotrypsin. The small degree of inhibition by these two 
compounds can be explained by the presence of organic 
solvents in the preincubation mixture. The most effective 
chemical modification reagent was p-chloromercuribenzoate 
(p-CMB) which covalently modifies sulfydryl groups. p-CMB 
inhibited tryptidase 85% at 0.05 mM . E-64, which inhibits 
. 
SH-enzymes, had no effect on tryptidase. DTT and 2-
mercaptoethanol neither inhibited nor stimulated activity. 
C:-Aminocaproic acid, which inhibits plasmin, also did not 
inhibit the enzyme. 
9. Time Course of Inhibition of Tryptidase by DFP 
When tryptidase was preincubated for increasing 
periods of time with DFP, its residual activity decreased as 
a function of time of preincubation as evidenced in Figure 
10. The pseudo-first order rate constant (Kobsd) for the 
reaction of the enzyme with DFP was 0.076 sec-1. The second 
order rate constant, Kobsd/[I], was 76 M-1 sec-1 . 
10. Effect of Metal Ions on Tryptidase Activity 
Table XV shows that none of the heavy metals, Mg++, 
Mn++, co++ 
I 
ca++, and Hg++, have any stimulatory effect on 
the enzyme. The only significant effect on tryptidase was 
by Hg++ which completely inactivates the enzyme at 2mM. The 
inhibition by mercury seen here is consistent with the 
inhibition seen with p-CMB above. 
11. Molecular Weight Determination by Gel Permeation 
TABLE XV 
EFFECT OF HEAVY METAL IONS ON TRYPTIDASE ACTIVITY 
Metal Ion 
Magnesium (Mg++) 
Manganese (Mn++) 
Cobalt (co++) 
Calcium (ca++) 
Mercury (Hg++) 
Concentration a 
(rnM) 
10 
10 
10 
10 
20 
2 
Percentb 
Inhibition 
0 
0 
12 
0 
10 
98 
7.42 
7.40 
7.27 
7.46 
7.48 
7.34 
99 
aAll stock solutions of metal ions were prepared in 
distilled deionized H2o except calcium (20 rnM) which was 
grepared in 0.1 M Tris, pH 7.5 buffer. 
Inhibition was measured using BAEE as substrate in a 1 ml 
assay. Concentration of BAEE was 1 rnM. 
cpH's represent measured values at the end of the reaction. 
Figure 10. Time course of inactivation of tryptidase by 
DFP. An aliquot of enzyme was preincubated with 
100 uM DFP in phos-EDTA-7.5 in a 40 ul volume 
for o, 5, 10, 15, 25 and 30 min and assayed in 
the preincubation cuvette for BAEE residual 
activity. Enzyme preincubated in the absence of 
DFP served as a control. The log % residual 
activity was plotted as a function of time. 
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Chromatography 
The molecular weight of tryptidase was estimated to 
be 158,000 by the method of Andrews (1965) when analytical 
high performance gel permeation chromatography was performed 
using a Toya Soda TSK SW-3000 column equilibrated with 1 M 
NaCl (Figure 11). Moreover, the enzyme eluted in a single 
symmetrical sharp band (Figure 12 A). 
Chromatography of the enzyme on the same column 
equilibrated with either 0.5 M NaCl (Figure 12 B) and 0.05 M 
NaCl (Figure 12 C) produced no major shift in the elution 
time of the enzyme. This suggests that in the absence of 
high salt, there is neither a formation of higher molecular 
weight aggregates nor dissociation of the enzyme into lower 
molecular weight monomeric subunits. 
12. Molecular Weight Determination Based on SDS 
Polyacrylamide Gel Electrophoresis 
When SDS polyacrylamide gel electrophoresis was 
performed on tryptidase, a single band was observed with a 
Mr = 40, 000 in both reducing and non-reducing gels (cf. 
Figure 4 and Figure 13). When the enzyme was inactivated 
with [3H]-DFP and run under non-reducing conditions, the 
label corresponded with the protein band (cf. Figure 5). 
This was also the case when labelled enzyme was run under 
reducing conditions. These results suggested that there was 
only one DFP-sensitive enzyme which corresponded to the 
majority of the protein in the preparation. The absence of 
Figure 11. Molecular weight of tryptidase by high per-
formance gel permeation chromatography. 
Trypptidase, as well as the molecular weight 
standards, glutamate dehydrogenase, rabbit 
muscle aldolase, bovine serum albumin, egg 
albumin and ribonuclease were applied to a 
Toya Soda TSK-gel SW-3000 column equilibrated 
with phos-EDTA-1 M NaCl-6.0 and fractions were 
collected at 5 min intervals. A standard curve 
was generated by plotting the molecular sieve 
coefficient (cs-) as a function of the log of the 
molecular weight of the standards. 
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Figure 12. Molecular weight of tryptidase by high 
performance gel permeation chromatography at 
high, medium, and low NaCl concentrations. 
Tryptidase was applied to a Toya Soda TSK-gel SW 
3000 column equilibrated in (A) phos-EDTA-1 M 
NaCl-6.0, (B) phos-EDTA-0.5 M NaCl-6.0 and (C) 
phos-EDTA-0.05 M NaCl-6.0. The enzyme was 
converted to the corresponding equilibration 
buffer before injection onto the column. The 
A214 of the fractions collected at 5 min 
intervals was monitored as a function of time. 
All other conditions for the experiment were 
similar to those described for Fig. 11. 
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Figure 13. Molecular weight of tryptidase by SDS gel 
electrophoresis. The enzyme was electrophoresed 
in SDS polyacrylamide gels under both reducing 
and non-reducing conditions as described in 
METHODS. Molecular weight markers were bovine 
albumin, egg albumin, glyceraldehyde-3-
phosphate dehydrogenase, carbonic anhydrase, 
trypsinogen, soybean trypsin inhibitor andot.-
lactalbumin. The mobility of the markers was 
calculated as described in METHODS and plotted 
against their corresponding molecular weight to 
generate a standard curve. 
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a different molecular weight band under reducing conditions 
suggests that the subunits of tryptidase are essentially 
single polypeptide chains. 
13. Isoelectric Focusing Of Tryptidase 
The pl of tryptidase was determined using precast PAG 
plates containing ampholytes in the pH range of 3. 5-9. 5. 
After completion of focusing, the gels were immediately 
fixed and then stained with Coomassie brilliant blue. Five 
bands in close proximity to each other were observed (Figure 
14) suggesting microheterogenei ty of the enzyme. Such a 
phenomenon is not surprising in view of the glycoprotein 
nature of the enzyme. The pl of tryptidase corresponding to 
these bands ranged from 4.5 to 4.9 with the most prominent 
band at 4.8. Calculations of pl were based on the standard 
curve given in Figure 15. 
14. Substrate Profile of Tryptidase 
A number of single amino acid synthetic ester and 
amide substrates as well as a whole range of 
tri(tetra)peptide p-NA substrates were assayed in order to 
determine the substrate specificity of tryptidase. 
a. Single Amino Acid Substrates 
Table XVI contains the list of single amino acid 
substrates which were tested against the enzyme. Of the 
trypsin-type substrates, tryptidase cleaves BAEE the best. 
The enzyme is unable to hydrolyze the chymotrypsin substrate 
ATEE. The tryptase substrate TAME is cleaved at only 50% 
Figure 14. Isoelectric focusing of tryptidase. The 
experiment was conducted according to the 
protocol described in detail in METHODS. 
Coomassie brilliant blue was used to stain the 
enzyme and pI marker proteins. Lanes A and E 
contain the marker proteins: a) amyloglu-
cosidase, b) soybean trypsin inhibitor, c) ~­
lactoglobulin, d) carbonic anhydrase (bovine), 
e) carbonic anhydrase (human), myoglobin, f) L-
lactate dehydrogenase and g) trypsinogen. Lanes 
B--c and F--G contain qnly tryptidase from two 
different preparations. 
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Figure 15. Isoelectric focusing of tryptidase. The 
experiment was conducted according to the 
protocol described in detail in METHODS. 
Coomassie brilliant blue was used to stain the 
enzyme and the following pI marker proteins: 
amyloglucosidase, soybean trypsin inhibitor, ~­
lactoglobulin, carbonic anhydrase (bovine), 
carbonic anhydrase (human), myoglobin, L-lactic 
dehydrogenase and trypsinogen. The pI's of the 
marker proteins were plotted as a function of 
their distance of migration from the anode. 
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TABLE XVI 
HYDROLYSIS OF SINGLE AMINO AC~D SUBSTRATES 
BY PURIFIED TRYPTIDASE 
SUBSTRATE ACTIVITY (U/ml) % MAXIMUM 
BAEE 
TAME 
BAPNA (D, L) 
ATEE 
All assays were conducted 
spectrophotometer at 250 in a 
Concentrations of all substrates 
mM. Assays for TAME were done at 
nm, and for ATEE at 237 nm. 
2.93 100 
1.28 43.7 
0.16 5.46 
o.o 0 
in a Gilford Response 
final volume of 1 ml. 
in the final assay was 1 
246 nm, for BAPNA at 410 
115 
the BAEE rate. The enzyme also clearly hydrolyzed the ester 
substrate BAEE faster than it did the amide substrate BAPNA. 
In assaying BAPNA, two different stock solutions were used. 
One contained the L-isomer of the amino acid (data not 
shown) and the other contained a mixture of the D- and L-
isomers (Table XVI) . Cleavage of the mixture of isomers 
proceeded at a significantly slower rate than cleavage of 
' the pure L-f orm suggesting that tryptidase has a 
stereospecific preference for the L-form. The lower rates 
seen with the mixture may also be due to inhibition produced 
by the D-form. 
b. Hanes-Woolf Plots for BAEE and BAME 
Plots of [S]/v vs. [SJ for BAEE and BAME as 
substrates for tryptidase are represented in figure 16 and 
17, respectively. The enzyme was assayed with each of these 
substrates at concentrations ranging from 0.5 Km to at least 
5 Km using the standard assay described in METHODS. The 
plots showed that the Km for BAEE was 0.0128 mM and the Vmax 
was 11 umoles/min. In the case of BAME the Km was 0.0196 mM 
and the Vmax was 16.2 umoles/min. 
The data obtained in these experiments were also 
analyzed by several other graphical methods by means of a 
computer program. The results are shown in Table XVII. 
Close agreement between values for the Km and Vmax was seen 
irrespective of the analysis used with the exception of the 
Lineweaver-Burke plot for BAME. 
Figure 16. Hanes plot for BAEE. The experiment was 
performed using the standard assay described 
in METHODS at different concentrations of 
substrate and identical aliquots of enzyme. 
Each point is an average of two values. 
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Figure 17. Hanes plot for BAME. The experiment was per-
formed in a manner similar to that described 
for Figure 16, substituting BAME as the sub-
strate. Each point is an average of two 
values. 
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TABLE XVII 
KINETIC PARAMETERS FOR TRYPTIDASE 
PLOT TYPE 
Direct Plot 
Lineweaver-Burke 
Hanes-Woolf 
Eadie-Hofstee 
Direct Plot 
Lineweaver-Burke 
Hanes-Woolf 
Eadie-Hofstee 
Km 
(mM) 
0.0134 
0.0134 
0.0128 
0.0128 
0.0202 
0.0367 
0.0196 
0.0222 
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Vmax 
(umoles/min) 
11. 0 
11. 2 
11. 0 
11. 0 
15.9 
21.5 
16.2 
17.0 
All assays were conducted at 25°, in duplicate, in a Gilford 
Response spectrophotometer for 5 min and initial velocities 
obtained through its builtin program. Range of substrate 
concentrations used spans 0.5 Km to 10 Km· Values for Km 
and Vmax were computer calculated using the Enzpack program 
(Elsevier Publications) 
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c. Tri- and Tetrapeptide p-Nitroanilide Substrates 
The longer p-NA substrates which were used to study 
the specificity of the enzyme are listed in Table XVIIIa and 
Table XVIIIb. A clear pattern emerges from the table that 
suggests that the enzyme in trypsin-like fashion favors a 
charged basic residue in the P1 position (cf. Schecter and 
Berger (1967) for terminology). Furthermore, of the two 
basic amino acids, arginine seems to be favored over lysine 
since activity against H-D-Val-Leu-Arg-pNA is about four 
times higher than against H-D-Val-Leu-Lys-pNA. However, the 
activity with Tos-Gly-Pro-Lys-pNA is slightly higher than 
with Tos-Gly-Pro-Arg-pNA. Proline in the P2 position also 
seems to be important. The most rapidly cleaved substrate, 
H-D-Ile-Pro-Arg-pNA, has a proline in that position as does 
four of the five best substrates. As far as the P3 site on 
the substrate is concerned, substrates with a hydrophobic 
amino acid in that position along with proline and arginine 
in the P2 and P1 positions, respectively, show good activity 
with the enzyme. 
15. Tryptidase and Larger Peptides 
Vasopressin (AVP), oxytocin and bradykinin are three 
of the larger peptides that were assayed for cleavage by 
tryptidase. Figure 18 shows chromatograms obtained using 
HPLC which demonstrate that there were no detectable 
products formed from either bradykinin (Figure 18 A) or 
oxytocin (Figure 18 B). However, AVP was hydrolyzed at the 
COM. NAME 
S-2288 
Spectre-
zyme Ca 
S-2238 
Chrome-
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TABLE XVIII 
TRI(TETRA)PEPTIDE pNA SUBSTRATE PROFILE 
OF PURIFIED TRYPTIDASE 
SUBSTRATE 
SEQUENCE 
H-D-Ile-Pro-Arg-pNA 
H-D-Pro-Pro-Arg-pNA 
H-D-Phe-pip-Arg-pNA 
H-D-Val-Gly-Arg-pNA 
ACTIVITY % MAXIMUM 
umol/min/ml 
41.1 100 
36.6 88.5 
27.3 66.5 
18 43.8 
zyme Try 
Chrome- Tos-Gly-Pro-Lys-pNA 15.7 38.2 
zyme p 
S-2222 Bz-Ile-Glu-(-0-Ra)Gly-Arg-pNA 13.8 33.7 
Chrome- Tos or CBZ-Gly-Pro-Arg-pNA 11. 8 28.7 
zyme TH 
S-2337 Bz-Ile-Glu-(-o-Rb)Glu-Arg-pNA 9.92 24.1 
C1E-l C2H50-Lys- (<;- -CBO) -Gly-Arg-pNA 7.99 19.4 
S-2266 H-D-Val-Leu-Arg-pNA 5.89 14.3 
CBS 34.47 H-D-CHG-But-Arg-pNA 4.53 10.9 
S-2160 Bz-Phe-Val-Arg-pNA 3.06 7.4 
CBS 31. 39 CH3-S02-D-Leu-Gly-Arg-pNA 2.30 5.6 
S-2251 H-D-Val-Leu-Lys-pNA 1.59 3.9 
Bz-Pro-Phe-Arg-pNA 1. 36 3.3 
S-2302 H-D-Pro-Phe-Arg-pNA 1.19 2.9 
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TABLE XVIII b 
TRI(TETRA)PEPTIDE pNA SUBSTRATE PROFILE 
OF PURIFIED TRYPTIDASE (contd.) 
SUBSTRATE 
COM. NAME SEQUENCE 
Spectre- H-D-Nleu-CHT-Lys-pNA 
zyme-PL 
S-2586 MeO-Suc-Arg-Pro-Tyr-pNA 
S-2484 <Glu-Pro-Val-pNA 
Spectre- H-D-Pro-HHT-Arg-pNA 
zyme-PKal 
Chrome- H-D-Val-CHA-Arg-pNA 
zym GK 
ACTIVITY % MAXIMUM 
umol/min/ml 
1. 02 2.5 
0.014 0.03 
0 0 
0 0 
0 0 
Concentrations of all substrates in the assay mixture were 1 
mM. Assays were conducted at 300, in a Multistat III F/LS 
centrifugal analyzer, in a total volume of 0.25 ml. 
aR = CH3 or H; bR = Piperidyl 
Figure 18. Hydrolysis of nonapeptides by tryptidase. 
Bradykinin (A), Oxytocin (B) and [8-Arginine] 
Vasopressin (C) were screened for cleavage by 
the enzyme using procedures described in 
METHODS. After incubation the enzyme was 
eliminated using a PM-30 Amicon membrane and the 
filtrate was chromatographed by HPLC using 
conditions given in METHODS. Eluent peaks were 
detected by UV absorbance at 214 nm. The 
downward arrow indicates the injection point for 
the filtrate. Time scale for A is 50 min and 
for B and C is 20 min. 
+- n .... 
( .,.._D~-OXY 
""'- AVP 
DG-AVP 
r 
I 
b:I . ... 
OXY .,..Ser-Pro 
+-Phe 
._Gly-Phe 
.,_BK(2- 7) 
.,_Phe-Arg 
.,_BK(l-5) 
._I3K(2-9) 
> 
BK(l-9) 
126 
Arg8-GlyNH2 bond to yield (desGly-NH2 )AVP (Figure 16C). 
Further verification that Gly-NH2 was released from AVP by 
the enzyme was obtained by using AVP which was radioactively 
labelled in this moiety. When this substrate was incubated 
with the enzyme, a [14c]-Gly-NH2 peak was detected by HPLC 
using a flow through radioactive scintillation detector. No 
such peak was evident in controls that had no tryptidase. 
The pH optimum for AVP cleavage was determined and 
the results are expressed in Figure 17. Tryptidase cleaved 
AVP optimally at pH 7. 5 which is also the optimal pH for 
BAEE hydrolysis. 
16. Tryptidase Assays for Proteinase Activity 
In casein-agar plate assays (Figure 18), no zones of 
lysis were seen which were similar to those seen for trypsin 
controls. The quantity of enzyme used was equivalent in 
BAEE activity to the corresponding control used. 
Similarly, as shown in Table XIX no proteinase 
activity for tryptidase was detected when haemoglobin or 
azocoll (a collagen substrate with an azo dye prepared from 
cowhide) was used as a substrate. Substantial cleavage of 
these substrates was observed in controls in which trypsin 
was substituted for tryptidase. 
assays contained twice the 
corresponding trypsin control. 
In these cases, tryptidase 
BAEE activity of the 
17. Active Site Titration of Tryptidase 
Since NPGB and MUGB were shown to inhibit the enzyme, 
Figure 19. pH optimum for [8-Arginine] Vasopressin. 
Buffers (O.l M) were prepared as described in 
METHODS. The enzyme was incubated in 113 ul of 
each buffer for 17 h at room temperature at the 
end of which the reaction was terminated using 
10 mM heptane sulfonic acid phosphate, pH 2.5 
and the enzyme was removed by filtration 
through a PM-30 Amicon membrane. Filtrates 
with their corresponding controls were then 
chromatographed by HPLC. Incubations contain-
ing no enzyme served as controls. The area 
under the peaks detected for desglycinamide 
vasopressin (DG-AVP) were calculated and used to 
determine the % of AVP cleaved which was then 
plotted as a function of pH. 
100 
90 
80 
0 
w 
70 ! > <( 
w 
_J 60 I 
u 
Q_ 50 t > 
<( 
40t LL 
0 30. 
6~ 
20 
10 
0 
3.5 
0-0 Acetate 
•-• Succinate 
D-D Phosphate 
•-•Tris 
D-D Borate 
ED 
4.5 5.5 6.5 
pH 
Figure 20. Assay for caseinolytic activity by tryptidase. 
Details of the protocol used to prepare the 
casein agar plates are described in METHODS. 
Trypsin was used as a control and an aliquot of 
enzyme equivalent to the BAEE activity of 
trypsin was used. The enzyme buffer and the 
buffer used to reconstitute trypsin were also 
run as controls. Clear areas around trypsin 
controls indicate cleavage. No such cleavage 
was apparent around wells containing buffer 
controls or enzyme. 
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TABLE XIX 
EFFECT OF TRYPTIDASE ON PROTEIN SUBSTRATES 
PROTEIN TYPE OF ASSAY HYDROLYSIS 
TRYPSIN TRYPTIDASE 
CASEIN agar gel +++ 
AZOCOLL colorimetric +++ 
(azo dye) 
HAEMOGLOBIN Colorimetric +++ 
(Folin reagent) 
The amount of protein in the assay was 18.5 g/l in the case 
of casein and haemoglobin and 23 g/l in the case of azocoll. 
All assays were performed at 25° and incubation was for 30 
min. Absorbances for azocoll were read at 520 nm and for 
haemoglobin at 578 nm. Further details of the assays are 
given in METHODS. 
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it was possible to attempt to use them as active site 
titrants to stoichiometrically quantitate the enzyme as has 
been done for trypsin (Jameson et al., 1976). Since NPGB 
requires the use of a spectrophotometric assay with a limit 
of detection of 1 uM, it was impossible to use the reagent 
because of the large amounts of enzyme required to make 
valid measurements. MUGB, which is used in a fluorescent 
assay with detection possible in the pM range, was therefore 
used for tryptidase. A 50 nM concentration of MUGB was used 
in the assays. Figure 21 depicts curves of change in % 
fluorescence versus time for varying quantities of enzyme. 
The pattern of the curves indicates an initial rapid 
undetected "burst" followed by a plateau phase which 
presumably represents an acylenzyme intermediate that turns 
over very slowly (see Discussion). 
Figure 22 expresses the burst in terms of % 
fluorescence as a function of the volume of enzyme solution 
used. The linearity of the curve is proof that 
extrapolation of the plateau phase in Figure 19 to the y 
axis is a good measure of the stoichiometric quantity of the 
enzyme, and is not a substrate depletion phenomenon. 
Moreover, an aliquot of enzyme assayed at double and triple 
the MUGB concentrations gave the same quantitative "burst". 
The % fluorescence corresponding to the burst of the 
enzyme was used to determine the molarity of the enzyme from 
a standard curve of concentration of methyl umbelliferone 
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Figure 21. Active site titration of tryptidase. The 
protocol used in this experiment is described in 
detail in METHODS. The % fluorescence as a 
function of time was monitored for 5 ul, 10 ul 
and 20 ul volumes of the enzyme. The burst was 
extrapolated to the ordinate axis and the size 
of the burst determined after subtraction of the 
MUGB blank. 
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Figure 22. Active site titration of tryptidase. The 
experiment was performed as described in Fig. 
21. The "burst" was expressed as % fluoresence 
and was plotted as a function of enzyme volume 
used in the assays. Enzyme aliquots used were 
from the same preparation. 
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(MU) vs. % fluorescence. The results obtained are shown in 
Table XX. The table shows that estimates of the enzyme 
weight (ng) made on the basis of active site titration and 
the enzyme molecular weight match very closely the weight 
calculated on the basis of the Bradford protein assay. This 
serves as a further proof of the purity of the enzyme, 
indicating the absence of non-enzymatic protein 
contamination. 
18. Partial N-Terminal Sequence of Tryptidase 
The N-terminal sequence of tryptidase has been 
obtained to the first 25 amino acids (Figure 23). This 
region shows 40% homology with trypsin. 
amino acids are identical to that of 
Residue 21 is a putative glycosylation 
The first four 
bovine trypsin. 
site due to the 
threonine at position 23. Based on this partial sequence 
figure 23 shows that tryptidase can be distinguished from 
other well known serine enzymes. 
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TABLE XX 
ACTIVE SITE TITRATION-BASED STOICHIOMETRIC 
ENZ. VOL. 
(ul) 
5 
10 
20 
QUANTITATION OF TRYPTIDASE 
ENZ. WTa 
(ng) 
270 
541 
1080 
"BURST"b QUANTITATION 
pmolesc weightd(ng) 
6% 7.1 284 
12% 15.5 620 
22.5% 30.2 1200 
aweight of enzyme in corresponding volume based on Bradford 
microassay estimations 
bBurst is the % fluorescence obtained on extrapolation of 
curves shown in Fig. 19 back to the y axis minus inherent 
substrate fluorescence, 
Ccalculations are based on a standard curve of % 
fluorescence vs. concentration of methylumbelliferone, for 
which m= 0.714, c= 0.948 and the RVal= .998 
dEstimates based on a molecular weight of 40,000 determined 
from SDS polyacrylamide gels. 
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Figure 23. Partial N-Terminal Sequence of Tryptidase. 
25 ng of enzyme were processed as described in 
METHODS. The amino acid sequencing was a 
commercial courtesy of Applied Biosystems 
Incorporated (ABI). Amino acid sequences for 
the other serine proteases were from a) Mikes 
et al., (1966), b) Shotton and Hartley (1970), 
c) Chung et al., (1986), d) Woodbury et al., 
(1978), e) Woodbury et al., (1978), f) Thomas 
and Bradshaw (1981), g) Fock-Nuzel et al., 
(1980), h) Wiman (1977), i) Zwilling et al., 
(1975), j) Franz (1977), k) Cromlish et al., 
(1987), 1) Lottspeich et al., (1979), m) Cool 
et al., (1985). Boxed segments indicate 
homology with tryptidase. 
l 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
Tryptidose Ile-Vol-Gly-Gly Gln-Glu-Ala-sar-Glyt••n1Lya-TrptPro~rp Gln-Val-Ser-Lou Arq-Val- -Asp-Thr-Tyr-Trp-
( rat) • 
Trypsina Ile-Val-Gly-Gly Tyr-Thr-cys-Gly-Ala Aan Thr-Val Pro Tyr Gln-Val-ser-Leu Aan-SEr-Gly-Tyr-Hia-Phe-cya-
( bovine) r::-;-:i 
Chymotrypsin Ablr1e-va1fAan~GlutG1u-AlatVal-Pro-Gly-SertTrp-Pro-Trp-Gln-va1fser-r.eutG1n-A•p-Ly•-Thr-Gly-Phe-Hi•-
(bovine) r.;:;i_ .r:::l 
Kallikreinc !r1e-Val-Gly-GlytThr-Aan-serfsertTrp-Gly-GlufTrp-Pro-Trp-Gln-va1-ser-LeufGln~Lya-Leu~Ala-Gln-
(human, bovine) 
(2 cha~na) ~ 
Elastase va1fval-Gly-GlyrThrlGlu-A1arG1n-ArgfA•nrsertTrp-ProtS•r~I1etser-LeutG1n-Tyr-Arg-ser-Gly-ser-ser-
(porcine) 
BMCP Id ~la Ila Gly-Gly Val~lutSer-Arg-Pro-His-Sar-ArqtProl"r-Met-Ala-Hia-Lou-Glu-ILo-Thr-Thr-
( rat) 
BMCP II8 Ile Ile Gly-Gly Val lu Ser-Ile-Pro-Hia-Ser-Ar9 Pro Tyr-Met-Ala-Hia-Leu-Aap-Ile-Val-Tbr-
( rat) r.::l .r;;:;-t_ 
!.::H.Glf IIle-Val-Gly-GlytPhe-cya-Glu-Lya- ~Ser-GlniPro-TrptHia~Ala-Val-Tyr-Arg-Tyr-Tbr-GlnfTyrtLeu-
(•ouae) f 
Acrosin9 va1fva1-c1y-Gly~Met-serfA1arG1u-Pro-Gly-A1afTrp-Pro-TrprMet Val-ser-LeutGln-Ile-Phe-Met-Tyr-Hia-Aan-
(boar) 
Pl as1ainh Val f Val-Gly-Gly~cya-Val f AlarHia-Pro-Hia-SerfTrp-Pro-Trp-Gln-Val-Ser-Leu-ArgfThr-Arg-Phe-Gly-
( hwaan) 
Thro!Dbini II1e-Val~G1ufG1y-GlnjAapfA1arc1u-Val-Gly-Leu-serf Pro-Trp-Gln-ValtMetfLeutPhe-Ar9-
(pi9, bovfn•) 
Factor Xa [Ile-Val-Gly-GlytArg-Aap-cya-Aia-Glu-Gly-Glu-cya1Pro-Trp-GlnfAla-LaufLeutVal-Aan-
(bovine) r:-::1. 
B Kallikrein Bj jilefilefGly-GlytArgfGlutcya-Glu-Lya~ser-Hia1Pro-Trp-Gln-Val}Ala-Ile-Tyr-Hia-Tyr-Ser-ser-Pbe-Gln­
(porcine) 
(pancreatic) 
(A chaink 
Tryptase 
(human) 
(pituitap> 
Tryptase 
(human lung) 
Kall ikreinl 
(human urine) 
Tissue-PA 
(human)• 
[Ile-Val-Gly-Gly-Gln-Glu-Ala~Pro-
\I1e-Val-Gly-Gly-Gln-Glu-AlatPro-Arg-Ser-
[Ile-Val-Gly-GlytTrpiG1urcy1-Glu-Gln-Hia-Ser-GlnfPro-Trp-Gln~Ala-AlafLeu~Tyr-Hi•-Phe-serfThrtPhe-Gln­
~LysfGly-Glyf Leu1PharAla-Asp-Ile-Ala-ser-Hiaf Pro-Trp-GlntAla-Ala-Ile-Phe-Ala-Lya-Hia-Arg-Arg-Ser-
...... 
,j:>. 
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CHAPTER V 
DISCUSSION 
A. Purification Of Tryptidase 
There are obviously several BAEE hydrolyzing enzymes 
present in skin tissue (Fraki et al, 1983) . Of these, 
carboxamidopeptidase (cathepsin A) (Simmons & Walter, 1981) 
and tryptase (in non-skin tissue) have been purified to 
apparent homogeneity. The other enzymes have not been 
extensively purified and hence studies done on them describe 
the mixed characteristics of more than one enzyme. 
Tryptidase represents yet another BAEE hydrolyzing enzyme 
isolated from skin. Having pure tryptidase allows us to 
identify those characteristics which distinguish it from 
carboxamidopeptidase and tryptase of the skin as well as 
from similar enzymes from other tissue sources. 
The purification scheme developed for tryptidase has 
been optimized to yield pure enzyme in the least possible 
time with an economy of materials. The initial extraction 
step is the first example of this optimization. Previous 
workers had frequently used 1 M NaCl to extract skin 
proteases (Fraki et al., 1983). However in the case of 
carboxamidopeptidase from toad skin, a 1:1 dilution of the 1 
M NaCl extract was required to improve the efficiency of the 
subsequent ammonium sulfate step resulting in increased 
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volume (Simmons & Walter, 1981). Since Table I indicated 
that extraction of rat skin with 1 M NaCl did not yield 
significantly more BAEE activity than extraction with 0.5 M 
NaCl the latter concentration was chosen which eliminates 
the need for dilution. This economized on the use of both 
NaCl and (NH 4 ) 2so4 and reduced purification time by 
minimizing the volumes of extract that had to be handled . 
. 
Although the ammonium sulfate step results in only a small 
increase in purification it does help to concentrate the 
enzyme to a volume which is more manageable for subsequent 
chromatography. Furthermore almost 50% of the original 
starting protein is eliminated in this step. This appears 
to be important since an attempt to eliminate this step from 
the purification scheme and to apply the homogenate directly 
to a specific affinity column was not successful. Lipid and 
protein contaminants in the homogenate clogged the column. 
Even the use of filters did not prevent this from occurring. 
Initial studies were carried out on the use of ion 
exchange chromatography for the purification of the enzyme. 
However, since the procedures did not provide significant 
advantages and were time consuming, they were subsequently 
dropped from the preparation scheme. In retrospect, some of 
the problems encountered with ion exchange chromatography 
may have related to lack of knowledge at the time about the 
presence of multiple enzymes which cleave BAEE. 
The key step of the purification scheme is the dual 
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column specific affinity chromatography which utilizes A-
Gly-Gly-PAB and con A-agarose in tandem. In developing the 
PAB step, it was assumed that the enzyme which hydrolyzes 
BAEE would have an affinity for p-aminobenzamidine which has 
an amidino group similar to the arginine residue in the 
substrate. However, the bulk of the BAEE activity applied 
to the A-Gly-Gly-PAB column passed through it. This 
phenomenon occurred, although to different degrees, 
irrespective of whether the application of the sample to the 
column was done at room temperature or at 40. We have 
repeatedly shown that the lack of binding of most of the 
BAEE activity is not an overloading effect. This phenomenon 
confirms the presence of more than one BAEE hydrolyzing 
enzyme described in the literature (Fraki et al, 1983). It 
is possible that the glycyl-glycine spacer arm on the column 
may have provided additional specificity which allowed for 
selective adsorption of tryptidase but not other BAEE-
hydrolyz ing enzymes in the mixture. Indeed a p-
aminobenzamidine column with a caproic acid spacer arm 
adsorbed much more BAEE activity. 
Even greater purification is achieved in this step by 
exploiting the temperature dependence of the binding of 
proteins to specific affinity matrices. The binding 
affinity is inversely dependent on the temperature (Lowe & 
Dean, 1974). While tryptidase has a high enough affinity 
for the column to remain bound at both 40 and room 
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temperature, much contaminating protein which can bind at 40 
fails to bind at room temperature. As a result, better 
purification factors were achieved by running the column at 
room temperature. Thus, the purification scheme exploits 
the temperature dependence of the differential affinity of 
various enzymes and proteins for the A-Gly-Gly-PAB column. 
While the affinity for A-Gly-Gly-PAB is active site 
directed, the affinity of tryptidase for concanavalin A 
depends on binding to carbohydrate moieties. Since these 
two affinities occur at different parts of the enzyme 
molecule, it was possible to elute the enzyme from the first 
column directly onto the concanavalin A-agarose column. 
Benzamidine, which is used as a competitive ligand to elute 
the enzyme from the A-Gly-Gly-PAB column, can be easily 
diluted out in the process of binding, washing and eluting 
the enzyme from the Con A column. Thus there was no need to 
physically subject the enzyme to additional steps to remove 
the benzamidine and concentrate the enzyme for application 
to the Con-A column. 
of time and enzyme. 
This results in considerable savings. 
Concanavalin A covalently attached to agarose binds 
to glycoproteins (Bishayee and Bachhawat, 1974). This 
lectin is from jack bean (Canavalin ensiformis) and 
interacts specifically with glucose, fructose, mannose, and 
glucosamine and other sterically related sugars. Bound 
glycoproteins can be dissociated from Con-A by o<.-methyl-D-
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mannoside or ~-methyl-D-glucoside (reviewed in Lowe & Dean, 
1974). Thus the binding of tryptidase to the Con A column 
establishes the glycoprotein nature of the enzyme. 
Tryptidase elution from the column is achieved witho(-
methyl-D-mannoside (100 mg/ml). While the specific activity 
of tryptidase does not increase much during this step, it is 
an important part of the purification scheme since a 
contaminating protein(s?) eluting from the A-Gly-Gly-PAB 
column is eliminated (cf. Figure 3). Hence the step is 
essential in the present scheme to obtain the final pure 
enzyme. 
The salient features of the purification scheme for 
tryptidase are summarized below: 
a) The enzyme is not subjected to gross changes in 
buffer or pH or salt concentrations. 
b) The entire purification procedure, from tissue 
preparation (for 12 rat skins) until storage of 
concentrated final pure enzyme, can be achieved 
in 4 days. 
c) The procedure yields apparently homogeneous 
enzyme in essentially two steps. This is a rare 
achievement for a purification scheme starting 
with a tissue source. 
d) The presence of 1 rnM EDTA (or 0.02% NaN3) 
throughout the purification scheme prevents 
bacterial contamination of the preparation. 
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e) Both the A-Gly-Gly-PAB and Con-A affinity 
column used in the scheme can be regenerated and 
used repeatedly. (Repeated use of these columns 
through more than 15 preparations to date have 
yielded eminently reproducible results.) 
Tryptidase can be stored for extended periods of time 
without significant loss of activity in phos-EDTA-0.5 M 
. 
NaCl-6.0. The presence of salt is important to the long 
range stability of the enzyme even at 40. In its absence, 
the enzyme undergoes some form of irreversible denaturation. 
Whether the ionic components of NaCl prevent this by 
stabilizing the tetrameric form of the enzyme is not known. 
B. Selective Substrates for Monitoring the Purification 
of Tryptidase. 
The trypsin-like substrate BAEE was used to monitor 
most of the purifications in this project. However, because 
there are other enzymes beside tryptidase in the preparation 
which can cleave this substrate, the purification factors 
and recoveries calculated on the basis of BAEE do not give 
accurate reflections of these parameters for tryptidase. 
Calculations based on subtracting non-tryptidase 
breakthrough activity yielded better results. 
Much higher purification factors and recoveries were 
achieved when Chromozym PL, S-2288 and S-2238 were used to 
monitor the purification of tryptidase. The breakthrough 
from the PAB column showed very little activity against the 
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former two substrates. These facts suggest that Chromozym 
PL and S-2288 are highly selective for tryptidase in rat 
skin extract. Both of these substrates are tripeptide p-
ni troanilides. Their selectivity for tryptidase is based on 
two factors: a) other enzymes cleave this substrate poorly 
relative to BAEE and b) tryptidase has enhanced activity 
toward these substrates presumably because of the presence 
of P2 and P3 residues in the substrate which interact with 
an extended binding pocket at the enzyme active site. In 
fact, the rates for the tripeptides having an arginine 
residue in the P1 position are much higher than those seen 
for BAPNA which has only a single amino acid. 
c. Physical, Chemical, Enzymatic and structural 
Characteristics of Tryptidase 
Since early evidence collected on the enzyme 
suggested the likelihood of a novel enzyme, it was our goal 
to fingerprint the enzyme with respect to its physical, 
chemical, catalytic and structural properties. This would 
enable us to compare the enzyme with other enzymes of the 
skin and similar enzymes from other sources. 
1. Chemical Characteristics. 
Tryptidase was found to be partially stable over a 
wide range of pH's (3-8.5) in its purified state. Its 
maximum activity toward BAEE was at pH 7.5. Its pH optimum 
for the larger substrate vasopressin was also pH 7.5. The 
pH studies with BAEE were done at almost 100 times the 
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substrate Km and consequently may be expected to reflect 
primarily the effect of pH on enzyme turnover (kcat)· The 
increased turnover seen above pH 6.0 can be attributed to an 
amino acid residue in the active site of the enzyme that has 
a pKa of around 6.5. It has been suggested in the case of 
trypsin, chymotrypsin and other serine proteases that the 
deprotonation of a histidine residue above pH 6.5 is 
involved in the generation of catalytic activity (Kraut, 
1977; Huber and Bode, 1978). Tryptidase is a serine 
protease on the basis of its inhibition by DFP; hence its 
activity may be explainable in similar terms by analogy. 
Since the enzyme is also inhibited by TLCK which acts by 
alkylating a histidine in the active site of serine 
proteases, it is reasonable to suggest that a histidine is 
also present in the active site of tryptidase and plays a 
role in the "charge relay system". At pH's above 8. 5, the 
enzyme looses activity rapidly. This loss of activity can 
be explained, at least in part, in terms of the instability 
of the enzyme at these pH's. It is possible that these 
higher pH's result in the deprotonation of a residue that is 
important for the stability of the enzyme. It is noteworthy 
that the pH optimum of the enzyme is in the pH region where 
it is beginning to show instability. 
In the case of trypsin, an Asp-189 has been found in 
the binding pocket of the enzyme and has been implicated in 
the binding of substrate arginines or lysines (Huber & Bode, 
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1978) . At pH's close to the pH optimum at which the 
catalytic histidine is deprotonated this residue has a 
negative charge and can serve as a cationic binding site for 
the positively charged arginine or lysine residue. It is 
likely that a similar cationic binding site is available in 
tryptidase and confers on it its trypsin-like specificity 
for basic amino acid residues. 
Among the protein proteinase inhibitors tested 
against tryptidase, Trasylol was the only one that proved 
effective. SBTI, LBTI, ovoinhibi tor, and o<. 1 -anti trypsin, 
which are capable of inhibiting trypsin at a 1:1 molar ratio 
(Kassel, 1970a; 1970b; 1970c), had no effect even though 
higher molar excesses of these inhibitors were used in these 
experiments. The ratio of inhibitor to enzyme for Trasylol 
was one tenth that used for the other inhibitors. 
Four of the microbial inhibitors isolated from 
Actinomyces preparations by Umezawa and coworkers (Umezawa 
and Aoyagi, 1977), were tested, and only antipain and 
leupeptin were effective inhibitors of tryptidase. Both 
antipain (a tetrapeptide) and leupeptin (a tripeptide), 
which contain a c-terminal argininal and inhibit trypsin, 
were equally effective against the enzyme. However, 
chymostatin (a tetrapeptide with a c-terminal 
phenylalaninal) and elastatinal (a tetrapeptide with a c-
terminal alaninal), had no effect on the enzyme at 
concentrations as high as 200 ug/ml. Chymostatin and 
elastatinal likewise do not inhibit trypsin. 
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The aldehyde 
function of the basic residue in antipain and leupeptin is 
the likely cause of inhibition of tryptidase. Other 
microbial inhibitors that had no effect on tryptidase were 
pepstatin (an inhibitor of acid proteases) and bestatin (an 
inhibitor of aminopeptidases). 
The active site titrants of trypsin, NPGB and MUGB, 
were highly effective inhibitors of tryptidase. Inhibition 
by these esters is explained in terms of a rapid acylation 
step followed by a slow deacylation that results in a stable 
guanidinobenzoyl-enzyme intermediate (Chase & Shaw, 1970). 
The initial instantaneous hydrolysis of these substrates 
followed by slow turnover allows for the quantitation of the 
stoichiometric reaction between enzyme and substrate (Bender 
et al., 1970). Although the phenolic product of NPGB was 
not of practical use in quantitative determinations of 
tryptidase because of its limited sensitivity, the 
fluorescent product of MUGB, methylumbelliferone, was 
successfully used to quantitate tryptidase in the nM range. 
DFP inhibits proteinases and peptidases that contain 
a serine residue in their active sites by forming a 
phosphate ester with this residue. DFP is considered to be 
a group-specific inhibitor of serine proteases (Barrett, 
1977). Tryptidase was significantly inhibited by 1 mM DFP 
upon preincubation at pH 7.5 for 10 min, and essentially all 
of its activity was lost after a preincubation for 30 min at 
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pH 6.0. On the basis of this inhibition by DFP, tryptidase 
may be classified as a serine protease (peptidase). 
Detailed studies done on serine proteases indicate 
that they have a "charge relay system" at their active sites 
comprising a serine residue which is hydrogen bonded to a 
histidine residue which in turn is hydrogen bonded to an 
aspartic acid residue (Kraut, 1977). The histidine in this 
system is susceptible to covalent modification by 
chloromethyl ketone derivatives of certain amino acids. In 
the case of trypsin, TLCK alkylates the histidine at its 
active site (Powers, 1977). Since tryptidase is inhibited 
by TLCK it is possible that a similar reaction is taking 
place between the inhibitor and a histidine in its active 
center. However, in the case of tryptidase this point is a 
matter of conjecture since chloromethyl ketones are also 
known to react by alkylating the active site sulfhydryl 
groups of thiol proteases (Whitaker and Perez-Villasenor, 
1968) and there is evidence that the enzyme has a free 
sulfydryl group. 
p-Chloromercuribenzoate (p-CMB) reacts with free 
sulfydryl groups of proteins to form mercaptides (Barrett, 
1977). This inhibitor inactivates tryptidase almost 
completely at concentrations as low as 50 uM, implying that 
the enzyme contains a free sulfydryl group which could be at 
its active center or at some position where it can play a 
critical role in the conformation of the enzyme. If the 
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sulfydryl were responsible for catalysis, however, one would 
expect to see inhibition by E-64, which is not the case with 
tryptidase. The sulfydryl could lie uninvolved in the 
vicinity of the substrate binding site. When p-CMB reacts 
with the sulfydryl, the p-CMB group could sterically prevent 
the binding of substrate (Bai & Hayashi, 1975). The much 
smaller Hg++ ion is also able to inhibit the enzyme, but 
only at'mM concentrations (data not shown) suggesting that 
the relative bulkiness of p-CMB is important for its 
inhibitory activity. 
Throughout most of the purification scheme for 
tryptidase, the metal chelating agent EDTA is used in the 
buffer. However, during the concanavalin A-agarose step, 
EDTA was replaced with a bacteriostatic agent NaN3 which has 
no metal chelating properties. Whether or not EDTA is 
present has no effect on recoveries or activity of the 
enzyme, suggesting that the enzyme is not a metalloenzyme. 
Furthermore, heavy metal ions like magnesium (Mg++)' 
manganese (Mn++), cobalt (co++) and calcium (ca++) at 10 mM 
have no significant activating or inhibitory effect. Of the 
metal ion studies, only the mercury ion (Hg++) (at 2 mM) 
inhibited. 
Tryptidase, in contrast to tryptase, is not affected 
by the presence of salt as far as activity is concerned. 
However, it does require salt for long term stability. It 
is possible that in the total absence of NaCl, tryptidase 
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breaks down into inactive subunits. The lowest salt 
concentration used in the gel filtration experiments was 50 
mM which was still sufficient to keep the subunits together 
(cf Figure 12). Gel filtration on enzyme stored in the 
absence of salt and run on a column equilibrated in a buffer 
without salt should be able to prove or disprove this 
hypothesis. 
2. Physical Characteristics 
In analytical high performance gel permeation 
chromatography in the presence of 1 M NaCl, the molecular 
weight of tryptidase was determined to be 158, 000. No 
higher molecular weight aggregates were detected when the 
experiment was done at 0.5 M NaCl or again at 0.05 M NaCl. 
However, on sodium dodecyl sulfate (SDS) gel electrophoresis 
under non-reducing conditions, a single protein band 
corresponding to a molecular weight of 41,000 was detected. 
This suggests that tryptidase is a multimeric enzyme made up 
of at least 4 subunits. When SDS gel electrophoresis was 
performed under reducing conditions, no new bands were seen 
and only a single band corresponding to a molecular weight 
of 40, 000 was seen. Thus the subunit of tryptidase is a 
single polypeptide chain. Experiments in which radio-
labelled DFP was bound to the active site showed that the 
label migrated to the same position in the gel as the 
stained protein band under both reducing and non-reducing 
conditions. Calculations of the weight of the enzyme 
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protein based on the molarity of the enzyme determined by 
active site titration and a subunit molecular weight of 
about 40,000 closely approximated to Bradford protein 
estimates of enzyme protein within experimental error. This 
suggests that each subunit contains one active site. 
Whether the single subunit is active by itself is not known. 
Tryptase in its monomeric form is known to lose activity 
(Schwartz and Bradford, 1986a). 
Unlike trypsin, the pI of tryptidase is in the 
acidic range. When the enzyme was subjected to isoelectric 
focusing on PAG-plates up to five bands ranging in pI from 
4. 5 to 4. 9 were observed with the most prominent band at 
4. 8. This microheterogenei ty in pI is not surprising in 
view of the glycoprotein nature of tryptidase. Since sialic 
acid or phosphate can contribute to glycoprotein charge 
heterogeneity, treatment of the enzyme with a sialidase, 
alkaline phosphatase, or endoglycosidase H might remove 
these charges and cause all bands to focus together. 
The low pI of tryptidase implies that at pH's around 
7. 5 the enzyme has an overall negative charge. At these 
pH's the protein inhibitors SBTI, LBTI and ovomucoid would 
also be negatively charged. Trypsin on the other hand would 
be positively charged and hence would attract these 
inhibitors whereas tryptidase would repel them. Hence one 
possible explanation for the lack of effect of these 
inhibitors on tryptidase is that they might be unable to 
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approach the enzyme due to electrostatic repulsion. 
Trasylol, which is effective against tryptidase, is 
positively · charged and so would be able to approach the 
enzyme and inhibit it according to this hypothesis. 
c. Enzymatic Characteristics of Tryptidase 
The substrate screening suggested that tryptidase has 
a specificity for basic 
possible from the data 
amino acid residues. It is not 
available in this study to state 
conclusively that the enzyme has a preference for arginine 
over lysine. However, since activity against H-D-Val-Leu-
Arg-pNA is about four times higher than against H-D-Val-Leu-
Lys-pNA (cf Table XVIIIa), this may be an indication of such 
a preference. No cleavage of the chymotrypsin substrate, 
ATEE was observed. 
On the basis of its relatively high activity toward 
p-NA substrates having a praline or a praline analog in the 
P2 position on the amide side of arginine or lysine, it can 
be suggested that the enzyme may favor praline in this 
position. 
Tryptidase is further able to act on the larger 
peptide AVP, removing a glycinamide from the c-terminus of 
this nonapeptide. Interestingly, AVP has a praline in the 
P2 position (----Pro-Arg-GlyNH2). The pH optimum for AVP 
cleavage is the same as for BAEE which suggests that the 
mechanism of catalysis may have some similarities to that 
for BAEE. 
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The rate of cleavage of BAEE is greater than that of 
BAPNA. In this respect tryptidase behaves in a manner 
characteristic of serine proteases which hydrolyze ester 
bonds much faster than amide bonds. BAME and BAEE, two 
esters with the same acyl groups but different leaving 
groups are hydrolyzed with similar kcat' s. This suggests 
that the deacylation step is rate limiting in ester 
hydrolysis by tryptidase as it is for the serine protease 
chymotrypsin (Zerner et al., 1964). A "burst" followed by 
an extremely low turnover of the acyl-enzyme complex, as 
seen in active site titration experiments using MUGB, is 
even more dramatic evidence for the formation of an acyl 
intermediate and for rate-limiting deacylation. 
Three nonspecific protein proteinase 
casein, haemoglobin, and azocoll, were 
substrates, 
resistant to 
hydrolysis by tryptidase. Hence, there is no evidence at 
this time to suggest that tryptidase has proteinase 
activity. The casein-agar assay and azocoll assay were of 
sufficient sensitivity to detect any significant non-
specific proteinase activity if the enzyme has any. The 
nature of the assays however, precluded detection of any 
highly selective cleavage of these substrates. 
Nevertheless, the inability to demonstrate gross cleavage of 
these protein substrates indicates that the specificity of 
tryptidase is not as broad as that of trypsin. 
4. structural Characteristics of Tryptidase 
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The N-terminal sequence of tryptidase (cf Figure 23) 
shows that it shares several features in common with serine 
proteases. The first four amino acid residues, Ile-Val-Gly-
Gly is homologous to that of trypsin and several other 
serine proteases. The N-terminal isoleucine has been shown 
in trypsin and many other serine proteases to form an 
internal salt bridge upon zymogen activation (Ruhlmann et 
al., 1973; Young et al., 1978). Hence it is possible that 
tryptidase has a precursor. Tryptidase also has the glycine 
at residue 4 and the praline at residue 13 conserved, like 
all the serine proteases shown in Figure 23. These features 
corroborate the idea that tryptidase is a serine protease. 
The first seven amino acids of tryptidase are 
identical to those of human pituitary tryptase, and human 
lung tryptase. However a comparison of the rest of the 
known sequence of human pituitary tryptase (8 residues) and 
human lung tryptase (10 residues) with tryptidase shows that 
the sequences are not homologous, and moreover, do not even 
share a common type or kind of amino acid. These 
differences suggest that the tryptidase and tryptase are 
different enzymes. 
D. Tryptidase as a Novel Enzyme 
The profile of the various chemical, physical and 
catalytic properties of tryptidase described above suggests 
that the enzyme has some trypsin-like features. The pH 
optimum is close to that for trypsin. Inhibitors of trypsin 
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such as Trasylol, NPGB and MUGB also inhibit tryptidase. 
The specific ligand, p-aminobenzamidine, used to purify the 
enzyme, and benzamidine used to elute it from the A-Gly-Gly-
PAB column are both trypsin inhibitors. Tryptidase can also 
hydrolyze the trypsin-like substrates BAEE and BAPNA. Like 
trypsin, tryptidase is a DFP-sensitive serine protease. 
However, a number of other enzymes exist that share 
similar' characteristics with trypsin and yet differ from it. 
These need to be discussed with reference to tryptidase. 
The enzyme that shares the greatest similarities in 
properties with tryptidase is tryptase. Tryptase has been 
isolated and purified from human skin (Fraki & Hopsu-Havu, 
1975), human lung (Schwartz et al., 1981; Smith et al., 
1984), human pituitary 
uterine cervix (Ito et 
(Cromlish et al., 1987), 
al., 1980) and rat mast 
(peritoneal) (Kido et al., 1985a). 
human 
cells 
The rat mast cell tryptase is inhibited by antipain, 
leupeptin and aprotinin like tryptidase. However, unlike 
tryptidase it is also significantly inhibited by SBTI and 
i-antitrypsin as well as elastatinal at concentrations of 10 
uM. Another significant difference is that the mast cell 
enzyme activity doubles in the presence of calcium (10 mM). 
No such effect was seen with tryptidase. The molecular 
weight of tryptase determined by gel filtration is 140,000 
which is somewhat lower than that of tryptidase which is 
160,000. A series of seven tripeptidyl MCA compounds which 
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were previously tested as substrates for tryptase (Kida et 
al., 1985) were also assayed with tryptidase (data not 
shown). The specificity pattern for tryptidase is markedly 
different from that for tryptase assayed in the absence of 
the endogenous inhibitor trypstatin. 
With regard to tryptases from the other tissues 
mentioned above, the human skin tryptase is like tryptidase 
in not being inhibited by SBTI or LBTI. However p-CMB does 
not affect the enzyme at 100 uM whereas tryptidase is 
significantly inhibited at 50 uM. The pituitary tryptase is 
however, inhibited by p-CMB (1 mM). In contrast to 
tryptidase, pituitary tryptase is inhibited 85% by 20 mM 
cac1 2 and is inhibited only 9% by Trasylol at 200 ug/ml. 
Tryptase from the human tissue sources differs most 
significantly from tryptidase in the effect of NaCl on 
activity. Whereas there is no significant effect of salts 
on tryptidase at concentrations as high as 1 M, nearly 50% 
of tryptase activity is lost at a concentration of O. 4 M 
NaCl. Tryptase from the human source is also different from 
our enzyme in its significant activity against the synthetic 
substrate TAME. In comparison with BAEE, the activity 
toward this substrate is 3 0% higher for human skin enzyme 
(Fraki & Hopsu-Havu, 1975). Tryptidase activity toward TAME 
is 50% lower than that toward BAEE. Human tryptase is also 
inhibited by calcium ions. 
Tryptidase therefore appears to be different from the 
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rat mast cell tryptase by several criteria and also has 
important differences with respect to the human tissue 
tryptases. · Moreover, as discussed above the N-terminal 
sequence comparisons also show that the two enzymes are 
different. 
The other enzyme purified from skin tissue to 
apparent homogeneity is carboxamidopeptidase (Simmons & 
Walter,' 1980). Tryptidase is certainly distinct from this 
enzyme in its lack of chymotrypsin activity, and its 
insensitivity to chymotrypsin inhibitors. 
The substrate profile for tryptidase indicates that 
the best p-NA substrates are those which were designed for 
the assay of serine proteases such as thrombin, and plasmin 
(Fareed et al, 1983) . Tryptidase however, differs from 
thrombin in being inhibited by Trasylol, but not by « 1 -
proteinase inhibitor or by the thrombin specific inhibitor, 
hirudin (Barrett & McDonald, 1980). 
Tryptidase is also not inhibited by <= -aminocaproic 
acid or SBTI which are inhibitors of plasmin. Moreover, 
unlike tryptidase which has a single polypeptide chain 
subunit, plasmin is made up of two chains with the 25,000 
dalton light chain having the active site (Barrett & 
McDonald, 1980). The molecular weight of plasmin is about 
85,000 which is much higher than that of tryptidase (subunit 
of Mr = 40,000). 
The data from this study on tryptidase, including 
inhibitor profile, substrate 
physical characteristics were 
specificities, 
compared with 
161 
chemical and 
similar data 
tabulated in summary form for 59 serine proteases (Barrett 
and McDonald, 1980) . Based on this comparison tryptidase 
could not be identified with any of them. 
Besides, the N-terminal sequence of tryptidase was 
compared with those of several prominent serine proteases 
(cf Figure 23). This comparison shows that tryptidase 
shares several common characteristics of serine proteases 
with these enzymes as discussed earlier above. However the 
homology between these enzymes and tryptidase is not 
significant, and the sequence differences are sufficient to 
justify the suggestion that tryptidase is not one of them. 
A very important significant observation about the 
known serine proteases is that tryptase and now tryptidase 
are perhaps the only ones known to have a tetrameric form. 
It is therefore very likely that tryptidase is a novel 
trypsin-like skin enzyme, and possibly a novel trypsin-like 
protease in general. 
E. Physiological Role of Tryptidase 
Tryptidase could be involved in one or more of the 
physiological functions described for skin proteases (Fraki 
et al., 1983). If tryptidase is present in mast cells which 
do abound in skin it could have a role in inflammatory 
response. Such a role has been postulated for tryptase 
which is a mast cell enzyme (Kido et al., 1985). Tryptidase 
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could also be involved in peptide precursor processing, 
since it does seem to have a preference for a proline 
residue in the P2 position next to a basic residue in the P1 
position. "Proline-directed arginyl cleavage" has been 
recently proposed as a processing mechanism (Schwartz, 1986) 
for a number of prohormones. 
F. Future Studies Possible with Pure Tryptidase 
As demonstrated above, tryptidase was purified to 
apparent homogeneity. The availability of the pure enzyme 
makes it possible to raise antibodies against the enzyme 
which can then be used to determine the cellular and 
subcellular localization of the enzyme by immunocytochemical 
staining. This will be the first step in delineating the 
physiological role of this enzyme. Tryptidase-specific 
assays and tryptidase antisera can also be used to monitor 
enzyme levels in different physiological processes. 
Furthermore, techniques are being developed to identify the 
natural substrates of tryptidase. Besides, since the N-
terminal sequence of the enzyme is now known it should be 
possible with techniques common to molecular biology to 
isolate the precursor of the enzyme and even to identify its 
gene. 
The present study therefore is an important step in 
laying the groundwork for understanding the role and 
function of yet another protease that forms a part of the 
biochemical machinery of mammalian biological systems. 
RESEARCH SUMMARY 
This dissertation reports the isolation and 
characterization of a novel trypsin-like enzyme from rat 
skin. The enzyme has been provisionally named tryptidase 
since it is trypsin-like and has been shown to have 
peptidase activity. 
A purification scheme was developed which yields a 
homogeneous preparation of tryptidase in two main steps. 
The techniques and procedures were optimized to obtain a 
high yield of enzyme in minimal time. Minced skin tissue 
from 12 rats is homogenized at pH 7.0 in buffer containing 
0.5 M NaCl. Following (NH4 ) 2so4 fractionation (25-80%) of 
the extract, the 80% precipitate is dialyzed against pH 6.0 
buff er containing 0. 5 M NaCl. In the second step, the 
enzyme is applied to an agarose-glycyl-glycyl-p-
aminobenzamidine column maintained at room temperature. 
Tryptidase is eluted from this column with 0.1 M benzamidine 
onto a concanavalin A-agarose (con A) column equilibrated at 
40. The enzyme is eluted from the con A column with 100 
mg/ml o<-methyl-D-mannoside. 
The entire purification scheme can be completed in 
less than four days with purification factors of over 12,000 
and recoveries of approx. 28%. The apparent homogeneity of 
the enzyme was demonstrated by the presence of only a single 
band in sodium dodecyl sulfate {SDS) polyacrylamide gel 
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electrophoresis carried out under either reducing or non-
reducing conditions. Enzyme labeled at the active site gave 
a single labeled band which co-migrated in SDS gels with the 
single stained band. 
The chemical, physical and catalytic properties of 
tryptidase were studied. High performance gel permeation 
chromatography gave a Mr for the enzyme of approx. 160,000. 
In SDS gels under reducing and non-reducing conditions the 
enzyme has a molecular weight of approx. 40,000 indicating 
that the enzyme is a tetramer made up of identical subunits 
each consisting of a single polypeptide chain. On 
isoelectric focusing the enzyme displays microheterogeneity 
with bands occurring in the pI range 4. 5 to 4. 9 with the 
band at 4.8 being the most prominent. 
Tryptidase is inhibited by the trypsin inhibitors p-
ni trophenyl-p' -guanidinobenzoate, p-methylumbelliferyl-p'-
guanidinobenzoate, leupeptin, antipain and Trasylol, but 
unlike trypsin, tryptidase is not inhibited by soybean 
trypsin inhibitor, lima bean trypsin inhibitor and 
ovomucoid. Inhibitors like hirudin, pepstatin and bestatin 
have no ef feet on the enzyme. The enzyme is inhibited, 
however, by the serine protease inhibitor diisopropyl-
phosphofluoridate, the chloromethyl ketone derivative of 
tosyl lysine (Tos-Lys-CH2Cl) as well as the sulfydryl group 
reagent p-chloromercuribenzoate. 
Heavy metal ions like ca++, co++, Mg++ and Mn++ have 
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no activating or inhibiting effect on the enzyme. NaCl is 
not inhibitory but is necessary for long term stability of 
the enzyme. 
Tryptidase can hydrolyze the trypsin ester substrate 
benzoyl-arginine ethyl ester and the amide substrate, 
benzoyl-arginine p-nitroanilide. The enzyme has an extended 
binding pocket since it can cleave tripeptide substrates 
more efficiently than single amino acid substrates. Each 
peptide which has been shown to be cleaved has either an 
arginine or lysine on the carboxyl side of the scissle bond. 
Vasopressin can also be cleaved at the ArgB-Gly9-NH2 bond 
with an optimal pH of 7.5. 
The N-terminal sequence of the enzyme has been 
obtained to the first 25 amino acids: Ilel-va12-Gly3-G1y4-
Gln5-G1u6-A1a 7 -serB-Gly9-AsnlO_Lysll_Trpl2 _prol3_Trpl4_ 
Glnl5_va116_serl7_Leul8_Argl9_va120_~_21_Asp22_Thr23_Tyr24_ 
Trp2 5 . This region shows 40% homology with trypsin with the 
first four amino acids being identical to that of bovine 
trypsin. Residue 21 is a putative glycosylation site due to 
the threonine at position 23. 
Comparisons of the structural, physical, chemical and 
catalytic properties of the enzyme with other known serine 
proteases suggest that tryptidase is a novel trypsin-like 
enzyme from rat skin. 
A role in inflammatory response or prohormone 
processing has been postulated. 
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APPENDIX A 
Solution A 
Acrylamide 
BIS 
APPENDIX A 
Table A 
Stock Solutions and Reagents 
For SDS Gel Electrophoresis 
Distilled deionized H20 to 
Solution B 
Tris-OH 
Distilled deionized H20 to 
(adjust to pH 8.9 with HCl) 
Solution C 
SDS 
Distilled deionized H20 
Solution D 
Tris-OH 
Distilled deionized H20 
(adjust to pH 6.7 with HCl) 
30 g 
0.8 g 
100 ml 
36.6 g 
100 ml 
10 g 
100 ml 
5.89 g 
100 ml 
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Table B 
stock Solutions and Reagents 
For SDS Gel Electrophoresis Contd. 
Solution A 
Soluti'on B 
Solution C 
Dist. deion. H20 
Ammonium Per-
sulfate 
TEMED, diluted 
1:10 with dist. 
deion H20 
S tacking Ge 1 Spacer Gel { 3 % ) 
(12.5%) 
62.55 ml 
18.75 ml 
1.5 ml 
67 ml 
150 mg 
225 ul 
1.5 ml 
1. 875 ml 
0.15 ml 
12.225 ml 
15 mg 
75 ul 
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Table C 
Buffers and Staining Solutions 
For SDS Gel Electrophoresis 
Running Buffer (5 X Concentrated) 
Tris-OH 
Glycine 
Solution C 
Distilled deionized H20 to 
Staining Solution 
Coomassie Blue 
Methanol 
Acetic Acid 
Distilled Deionized H20 to 
Destaining Solution 
Methanol 
Acetic Acid 
Distilled deionized H20 to 
60 g 
288 g 
200 ml 
4 1 
0.5 g 
250 ml 
50 ml 
500 ml 
37.5 ml 
37.5 ml 
500 ml 
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Table D 
Solutions for Isoelectric Focusing 
On Polyacrylamide Gels 
Fixing Solution 
Trichloroacetic Acid 
Sulphosalicylic Acid 
Distiiled H20 
Staining Solution 
Coomassie Blue R 250 
Ethanol 
Acetic Acid 
Distilled H20 
Destaining Solution 
Ethanol 
Acetic Acid 
Distilled H20 to 
Preserving Solution 
Glycerol 
Ethanol 
Acetic Acid 
Distilled H20 
57.50 g 
17.25 g 
500 ml 
0.46 g 
100 ml 
40 ml 
260 ml 
500 ml 
160 ml 
2 1 
40 ml 
100 ml 
40 ml 
260 ml 
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